US20230128722A1 - Bead incubation and washing on a droplet actuator - Google Patents
Bead incubation and washing on a droplet actuator Download PDFInfo
- Publication number
- US20230128722A1 US20230128722A1 US18/063,874 US202218063874A US2023128722A1 US 20230128722 A1 US20230128722 A1 US 20230128722A1 US 202218063874 A US202218063874 A US 202218063874A US 2023128722 A1 US2023128722 A1 US 2023128722A1
- Authority
- US
- United States
- Prior art keywords
- droplet
- beads
- magnet
- magnetically responsive
- operations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011324 bead Substances 0.000 title claims abstract description 343
- 238000005406 washing Methods 0.000 title description 76
- 238000011534 incubation Methods 0.000 title description 58
- 238000000034 method Methods 0.000 claims abstract description 112
- 230000005291 magnetic effect Effects 0.000 claims abstract description 82
- 239000000427 antigen Substances 0.000 claims description 18
- 102000036639 antigens Human genes 0.000 claims description 17
- 108091007433 antigens Proteins 0.000 claims description 17
- 230000008569 process Effects 0.000 description 40
- 239000006228 supernatant Substances 0.000 description 34
- 238000003018 immunoassay Methods 0.000 description 33
- 239000012530 fluid Substances 0.000 description 32
- 239000000523 sample Substances 0.000 description 31
- 239000003153 chemical reaction reagent Substances 0.000 description 25
- 239000002699 waste material Substances 0.000 description 25
- 239000000463 material Substances 0.000 description 22
- 238000001514 detection method Methods 0.000 description 20
- 238000002156 mixing Methods 0.000 description 19
- 239000011534 wash buffer Substances 0.000 description 18
- 239000000758 substrate Substances 0.000 description 16
- 238000003556 assay Methods 0.000 description 11
- 230000001404 mediated effect Effects 0.000 description 10
- 238000009739 binding Methods 0.000 description 9
- 239000000945 filler Substances 0.000 description 9
- 102000013394 Troponin I Human genes 0.000 description 8
- 108010065729 Troponin I Proteins 0.000 description 8
- 239000012491 analyte Substances 0.000 description 8
- 230000027455 binding Effects 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 102000004127 Cytokines Human genes 0.000 description 7
- 108090000695 Cytokines Proteins 0.000 description 7
- 108090001005 Interleukin-6 Proteins 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 238000011068 loading method Methods 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 6
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 6
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 6
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 239000012139 lysis buffer Substances 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000013592 cell lysate Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- QDOXWKRWXJOMAK-UHFFFAOYSA-N dichromium trioxide Chemical compound O=[Cr]O[Cr]=O QDOXWKRWXJOMAK-UHFFFAOYSA-N 0.000 description 2
- 238000004720 dielectrophoresis Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- -1 for example Substances 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000002907 paramagnetic material Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000013076 target substance Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229910002771 BaFe12O19 Inorganic materials 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 208000005228 Pericardial Effusion Diseases 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000011166 aliquoting Methods 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 238000011021 bench scale process Methods 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 241000902900 cellular organisms Species 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(II) oxide Inorganic materials [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000002902 ferrimagnetic material Substances 0.000 description 1
- 239000003302 ferromagnetic material Substances 0.000 description 1
- 238000002637 fluid replacement therapy Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- GEYXPJBPASPPLI-UHFFFAOYSA-N manganese(III) oxide Inorganic materials O=[Mn]O[Mn]=O GEYXPJBPASPPLI-UHFFFAOYSA-N 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 238000001690 micro-dialysis Methods 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002102 nanobead Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- GNRSAWUEBMWBQH-UHFFFAOYSA-N nickel(II) oxide Inorganic materials [Ni]=O GNRSAWUEBMWBQH-UHFFFAOYSA-N 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 210000004912 pericardial fluid Anatomy 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000004911 serous fluid Anatomy 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
- B01F31/65—Mixers with shaking, oscillating, or vibrating mechanisms the materials to be mixed being directly submitted to a pulsating movement, e.g. by means of an oscillating piston or air column
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/30—Micromixers
- B01F33/302—Micromixers the materials to be mixed flowing in the form of droplets
- B01F33/3021—Micromixers the materials to be mixed flowing in the form of droplets the components to be mixed being combined in a single independent droplet, e.g. these droplets being divided by a non-miscible fluid or consisting of independent droplets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/30—Micromixers
- B01F33/3031—Micromixers using electro-hydrodynamic [EHD] or electro-kinetic [EKI] phenomena to mix or move the fluids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502761—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502769—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
- B01L3/502784—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for droplet or plug flow, e.g. digital microfluidics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502769—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
- B01L3/502784—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for droplet or plug flow, e.g. digital microfluidics
- B01L3/502792—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for droplet or plug flow, e.g. digital microfluidics for moving individual droplets on a plate, e.g. by locally altering surface tension
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/28—Magnetic plugs and dipsticks
- B03C1/288—Magnetic plugs and dipsticks disposed at the outer circumference of a recipient
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/30—Combinations with other devices, not otherwise provided for
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C5/00—Separating dispersed particles from liquids by electrostatic effect
- B03C5/005—Dielectrophoresis, i.e. dielectric particles migrating towards the region of highest field strength
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/1013—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by using magnetic beads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
- G01N33/561—Immunoelectrophoresis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/02—Adapting objects or devices to another
- B01L2200/026—Fluid interfacing between devices or objects, e.g. connectors, inlet details
- B01L2200/027—Fluid interfacing between devices or objects, e.g. connectors, inlet details for microfluidic devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0647—Handling flowable solids, e.g. microscopic beads, cells, particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0647—Handling flowable solids, e.g. microscopic beads, cells, particles
- B01L2200/0668—Trapping microscopic beads
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0654—Lenses; Optical fibres
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0864—Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0867—Multiple inlets and one sample wells, e.g. mixing, dilution
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/089—Virtual walls for guiding liquids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/18—Means for temperature control
- B01L2300/1805—Conductive heating, heat from thermostatted solids is conducted to receptacles, e.g. heating plates, blocks
- B01L2300/1827—Conductive heating, heat from thermostatted solids is conducted to receptacles, e.g. heating plates, blocks using resistive heater
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0415—Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0415—Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic
- B01L2400/0421—Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic electrophoretic flow
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0415—Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic
- B01L2400/0424—Dielectrophoretic forces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0415—Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic
- B01L2400/0427—Electrowetting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/043—Moving fluids with specific forces or mechanical means specific forces magnetic forces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0433—Moving fluids with specific forces or mechanical means specific forces vibrational forces
- B01L2400/0436—Moving fluids with specific forces or mechanical means specific forces vibrational forces acoustic forces, e.g. surface acoustic waves [SAW]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0442—Moving fluids with specific forces or mechanical means specific forces thermal energy, e.g. vaporisation, bubble jet
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
- B01L7/525—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples with physical movement of samples between temperature zones
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C2201/00—Details of magnetic or electrostatic separation
- B03C2201/18—Magnetic separation whereby the particles are suspended in a liquid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C2201/00—Details of magnetic or electrostatic separation
- B03C2201/26—Details of magnetic or electrostatic separation for use in medical or biological applications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/10—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
- G01N2035/1027—General features of the devices
- G01N2035/1034—Transferring microquantities of liquid
- G01N2035/1046—Levitated, suspended drops
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/11—Automated chemical analysis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25625—Dilution
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/2575—Volumetric liquid transfer
Definitions
- the method also comprises positioning a droplet having magnetically responsive beads therein at a location within the first region of the magnetic field of the magnet to form a concentration of beads in the droplet; transporting the droplet through activation of selected droplet operations electrodes away from the first region of the magnetic field of the magnet to resuspend the magnetically responsive beads in the droplet; operating the droplet operations electrodes to cause the droplet to elongate and then split into two droplets at a location away from the magnet; and operating the droplet operations electrodes to merge the two droplets into a single droplet at a location away from the magnet, whereby the transporting, splitting, and merging comprise an incubation cycle.
- FIG. 14 shows a plot of the kinetics of a reaction between a chemiluminescent substrate and ALP reporter on magnetically responsive beads for Troponin I (TnI);
- washing of magnetically responsive beads, where unbound molecules are separated and removed is one of the most critical steps in implementing an immunoassay in a digital microfluidic system.
- washing is performed using a merge-and-split protocol, which is repeated until the unbound material is sufficiently depleted from the supernatant to permit accurate and precise detection.
- Droplet actuator 500 may include a path or array of droplet operations electrodes 510 (e.g., electrowetting electrodes).
- a magnet 512 is arranged in close proximity to droplet operations electrodes 510 .
- magnet 512 is arranged such that certain droplet operations electrodes 510 (e.g., 3 droplet operations electrodes 510 M) are within the magnetic field of magnet 512 .
- Magnet 512 may, for example, be a permanent magnet or an electromagnet.
- Droplet actuator 500 may contain a wash buffer droplet 516 and a bead droplet 514 that may be transported along droplet operations electrodes 510 via electrowetting and upon which droplet operations may be performed.
- Bead droplet 514 may, for example, include a quantity of magnetically responsive beads 518 that includes bound antigen and reporter antibody (i.e., antigen-antibody-reporter complex), and unbound material such as excess unbound reporter antibody.
- a washing protocol may use a wash droplet and a bead droplet that are circular in shape.
- a circular shape of a droplet may, for example, be obtained by performing droplet operations on a 2 ⁇ wash droplet and a 2 ⁇ bead droplet using only one droplet operations electrode each. Because a 2 ⁇ droplet (i.e., footprint is approximately 2 times the area of one droplet operations electrode) is much larger than a single droplet operations electrode, the droplet takes a more rounded shape.
- FIG. 6 shows a plot 600 of a comparison of washing protocols between slug shaped and circular shaped wash droplets on immunoassay performance measured in chemiluminescence.
- incubation was performed using the off-magnet incubation protocol of FIG. 2 for 3 minutes.
- Each wash cycle takes about 10 seconds in a slug-based protocol of FIG. 5 and about 14 seconds in a circular droplet protocol.
- Droplet actuator 1000 may include a path or array of droplet operations electrodes 1010 (e.g., electrowetting electrodes).
- a magnet 1014 is arranged in close proximity to droplet operations electrodes 1010 .
- magnet 1014 is arranged such that certain droplet operations electrodes 1010 (e.g., 3 droplet operations electrodes 1010 M) are within the magnetic field of magnet 1014 .
- Magnet 1014 may, for example, be a permanent magnet or an electromagnet.
- FIG. 10 A shows a first step in a process of separating beads from a circular droplet.
- droplet 1016 that has beads 1020 therein is positioned at a droplet operations electrode 1010 M, which is within the magnetic field of magnet 1014 . Because beads 1020 are magnetically responsive, beads 1020 are attracted to magnet 1014 . Because a single droplet operations electrode 1010 M is active, droplet 1016 is circular in shape.
- FIG. 10 C shows yet another step in the process of separating beads from a circular droplet.
- droplet 1016 is transported via electrowetting further away from droplet operations electrode 1010 M and to a droplet operations electrode 1010 that is yet further away.
- the concentration of beads 1020 breaks away (snaps off) from droplet 1016 .
- one side e.g., the side nearest magnet 1014
- the opposite side e.g., the side farthest from magnet 1014
- a similar result can be achieved using a barrier that permits a bead-containing droplet to be transported while restraining transport of the beads with the main body of the droplet.
- FIGS. 11 A, 11 B, and 11 C show a top view of a region of a droplet actuator 1000 of FIGS. 10 A through 10 C and a process of transporting beads within a droplet.
- the method of the invention of FIGS. 11 A through 11 C is an example of a method wherein magnetically responsive beads are transported within an elongated droplet away from a magnetic force.
- droplet 1016 is a slug-shaped 3 ⁇ droplet that is processed using three active electrodes for each droplet operation.
- FIGS. 11 A, 11 B, and 11 C show the process steps of transporting beads 1020 within an elongated droplet 1016 away from magnet 1014 .
- one side e.g., the side nearest magnet 1014
- the opposite side e.g., the side farthest from magnet 1014
- electrowetting force occurs on both sides of droplet 1016 , all of the fluid within the droplet is electrowetted and beads 1020 are retained within droplet 1016 during droplet transport away from magnet 1014 .
- FIGS. 12 A, 12 B, and 12 C show a top view of a region of a droplet actuator 1000 and a process of separating beads from a sample droplet onto a magnet.
- the method of the invention of FIGS. 12 A through 12 C is an example of a method wherein magnetically responsive beads are split from an elongated droplet (e.g., 3 ⁇ droplet) onto a magnet.
- the method of the invention of FIGS. 12 A through 12 C may be used to dispense magnetically responsive beads onto a magnet.
- FIG. 12 A shows a first step in a process of dispensing beads from an elongated droplet.
- droplet 1016 that has beads 1020 therein is positioned at a droplet operations electrode 1010 M, which is within the magnetic field of magnet 1014 . Because beads 1020 are magnetically responsive, beads 1020 are attracted to magnet 1014 . Because three droplet operations electrodes 1010 are active, droplet 1016 is elongated in shape.
- FIG. 12 B shows another step in a process of dispensing beads from an elongated droplet.
- droplet 1016 is transported away from magnet 1014 via electrowetting using one active droplet operations electrode 1010 at a time.
- a concentration of beads 1020 is formed at the side of droplet 1016 that is closest to magnet 1014 . Because droplet 1016 is transported away from magnet 1014 one droplet operations electrode 1010 at a time, the geometry of droplet 1016 may be distorted.
- FIGS. 13 A and 13 B show a comparison of bench top and droplet actuator immunoassay reagent ratios and a plot of reagent concentration versus signal strength, respectively, that provide for optimum droplet based immunoassay performance.
- FIG. 14 shows a plot 1400 of the kinetics of a reaction between a chemiluminescent substrate and the ALP on magnetically responsive beads for Troponin I (TnI).
- Immunoassays were performed on TnI (100 ng/mL) using an on-magnet incubation protocol and a circular shaped droplet washing protocol. As shown in FIG. 14 , about 90% of the end point signal was obtained in about 120 to about 130 seconds. For a lower concentration of the analyte, maximum signal was achieved in about ⁇ 120 seconds. Based on this data, for the type of substrate used, 2 minutes may be selected as an optimum incubation time to generate maximum signal for the chemiluminescence reaction. However, if the chemiluminescence reaction is observed to behave as a flash signal instead of a glow reaction, the 2 minute incubation may be reduced to about a few seconds.
- a droplet of magnetically responsive beads such as paramagnetic Dynabeads® DNA Direct Universal from Dynal Biotech (1.05 ⁇ m diameter) suspended in a lysis buffer are dispensed from an on-chip reservoir and transported via electrowetting to a specific location on the chip.
- the beads, which are magnetically responsive, are held by a permanent magnet placed underneath the chip.
- the fluids may include one or more magnetically responsive and/or nonmagnetically responsive beads.
- droplet actuator techniques for immobilizing magnetically responsive beads and/or non-magnetically responsive beads are described in the foregoing international patent applications and in Sista, et al., U.S. Patent Application No. 60/900,653, entitled “Immobilization of Magnetically-responsive Beads During Droplet Operations,” filed on Feb. 9, 2007; Sista et al., U.S. Patent Application No. 60/969,736, entitled “Droplet Actuator Assay Improvements,” filed on Sep. 4, 2007; and Allen et al., U.S. Patent Application No. 60/957,717, entitled “Bead Washing Using Physical Barriers,” filed on Aug. 24, 2007, the entire disclosures of which is incorporated herein by reference.
- FIGS. 16 A and 16 B illustrate top views of an example of a portion of a droplet actuator 1600 and show a process of cytokine detection on a droplet actuator. All steps involved in the immunoassay, including sample and reagent aliquoting, incubation with antibodies, bead washing, and enzymatic detection, are fully automated and under software control.
- An example of a process of cytokine detection on a droplet actuator may include, but is not limited to, the following steps:
- Merged droplet 1618 is incubated for 4 minutes using droplet operations, as described in steps B and C of FIG. 16 A . Following the incubation period, droplet 1618 is transported to droplet operations electrode 1610 M and a supernatant droplet (i.e., a 1 ⁇ droplet) is split off using droplet operations, as described in step D of FIG. 16 A , in order to yield a 2 ⁇ droplet 1618 .
- the supernatant droplet (not shown) that includes unbound streptavidin-enzyme conjugate is discarded.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Clinical Laboratory Science (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Fluid Mechanics (AREA)
- Electrochemistry (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Methods are provided for separating magnetically responsive beads from a droplet in a droplet actuator. Droplet operations electrodes and a magnet are arranged in a droplet actuator to manipulate a bead-containing droplet and position it relative to a magnetic field region that attracts the magnetically responsive beads. The droplet operations electrodes are operated to control the droplet shape and transport it away from the magnetic field region to form a concentration of beads in the droplet. The continued transport of the droplet away from the magnetic field causes the concentration of beads to break away from the droplet to yield a small, concentrated bead-containing droplet immobilized by the magnet.
Description
- This application is a continuation of and incorporates by reference U.S. patent application Ser. No. 16/811,789, entitled “Bead Incubation and Washing on a Droplet Actuator” filed Mar. 6, 2020, which is a continuation of and incorporates by reference U.S. patent application Ser. No. 16/132,175 (now U.S. Pat. No. 10,585,090 issued Mar. 10, 2020), entitled “Bead Incubation and Washing on a Droplet Actuator” filed Sep. 14, 2018, which is a divisional of and incorporates by reference U.S. patent application Ser. No. 15/210,634 (now U.S. Pat. No. 10,078,078 issued Sep. 18, 2018), entitled “Bead Incubation and Washing on a Droplet Actuator” filed Jul. 14, 2016, which is a continuation of and incorporates by reference U.S. patent application Ser. No. 14/731,740 (now U.S. Pat. No. 9,395,361 issued Jul. 19, 2016), entitled “Bead Incubation and Washing on a Droplet Actuator” filed on Jun. 5, 2015, which is a continuation of and incorporates by reference U.S. patent application Ser. No. 14/466,193 (now U.S. Pat. No. 9,081,007 issued Jul. 14, 2015), entitled “Bead Incubation and Washing on a Droplet Actuator” filed on Aug. 22, 2014, which is a continuation of and incorporates by reference U.S. patent application Ser. No. 14/081,376 (now U.S. Pat. No. 8,846,410 issued Sep. 30, 2014), entitled “Bead Incubation and Washing on a Droplet Actuator” filed on Nov. 15, 2013, which is a divisional of and incorporates by reference U.S. patent application Ser. No. 13/081,927 (now U.S. Pat. No. 8,637,324 issued Jan. 28, 2014), entitled “Bead Incubation and Washing on a Droplet Actuator” filed on Apr. 7, 2011, which is a continuation-in-part of U.S. patent application Ser. No. 11/639,531 (now U.S. Pat. No. 8,613,889 issued Dec. 24, 2013), entitled “Droplet-based washing” filed on Dec. 15, 2006. U.S. patent application Ser. No. 14/466,193 (now U.S. Pat. No. 9,081,007 issued Jul. 14, 2015), is a continuation-in-part of U.S. patent application Ser. No.: 11/639,736 (now U.S. Pat. No. 7,439,014 issued Oct. 21, 2008), entitled “Droplet-Based Surface Modification and Washing” filed on Dec. 15, 2006; Ser. No. 12/113,385 (now U.S. Pat. No. 8,541,176 issued Sep. 24, 2013), entitled “Droplet-Based Surface Modification and Washing” filed on May 1, 2008, the application of which is a divisional of and incorporates by reference U.S. patent application Ser. No. 11/639,736 (now U.S. Pat. No. 7,439,014 issued Oct. 21, 2008); Ser. No. 12/615,609 (now U.S. Pat. No. 8,313,895 issued Nov. 20, 2012), entitled “Droplet-Based Surface Modification and Washing” filed on Oct. 10, 2009, the application of which is a continuation of and incorporates by reference U.S. patent application Ser. No. 12/113,385 (now U.S. Pat. No. 8,541,176 issued Sep. 24, 2013), which is a divisional of U.S. patent application Ser. No. 11/639,736 (now U.S. Pat. No. 7,439,014 issued Oct. 21, 2008); and Ser. No. 12/615,666, entitled “Droplet-Based Surface Modification and Washing” filed on Nov. 10, 2009, the application of which is a continuation of and incorporates by reference U.S. patent application Ser. No. 12/113,385 (now U.S. Pat. No. 8,541,176 issued Sep. 24, 2013), which is a divisional of U.S. patent application Ser. No. 11/639,736 (now U.S. Pat. No. 7,439,014 issued Oct. 21, 2008). U.S. patent application Ser. No.: 11/639,531 (now U.S. Pat. No. 8,613,889 issued Dec. 24, 2013) and Ser. No. 11/639,736 (now U.S. Pat. No. 7,439,014 issued Oct. 21, 2008) claim priority to and incorporate by reference related provisional U.S. Provisional Patent Application Nos.: 60/745,058, entitled “Filler Fluids for Droplet-Based Microfluidics” filed on Apr. 18, 2006; 60/745,039, entitled “Apparatus and Methods for Droplet-Based Blood Chemistry,” filed on Apr. 18, 2006; 60/745,043, entitled “Apparatus and Methods for Droplet-Based PCR,” filed on Apr. 18, 2006; 60/745,059, entitled “Apparatus and Methods for Droplet-Based Immunoassay,” filed on Apr. 18, 2006; 60/745,914, entitled “Apparatus and Method for Manipulating Droplets with a Predetermined Number of Cells” filed on Apr. 28, 2006; 60/745,950, entitled “Apparatus and Methods of Sample Preparation for a Droplet Microactuator,” filed on Apr. 28, 2006; 60/746,797 entitled “Portable Analyzer Using Droplet Based Microfluidics,” filed on May 9, 2006; 60/746,801, entitled “Apparatus and Methods for Droplet-Based Immuno-PCR,” filed on May 9, 2006; 60/806,412, entitled “Systems and Methods for Droplet Microactuator Operations,” filed on Jun. 30, 2006; and 60/807,104, entitled “Method and Apparatus for Droplet Based Nucleic Acid Amplification,” filed on Jul. 12, 2006.
- Additionally, U.S. patent application Ser. No. 13/081,927 (now U.S. Pat. No. 8,637,324 issued Jan. 28, 2014), is a continuation of, claims priority to, and incorporates by reference International Patent Application Ser. No. PCT/US2009/059868, entitled “Bead Incubation And Washing On A Droplet Actuator” International filing date of Oct. 7, 2009, the application of which claims priority to U.S. Provisional Patent Application Nos.: 61/103,302, filed on Oct. 7, 2008, entitled “Bead Incubation and Washing on a Droplet Actuator” and 61/122,791, filed on Dec. 16, 2008, entitled “Bead Incubation and Washing on a Droplet Actuator,” the entire disclosures of which are incorporated herein by reference.
- Each of the patents and patent applications provided herein is incorporated by reference in its entirety.
- This invention was made with government support under AI066590, HG003706, and CA114993 awarded by the National Institutes of Health. The United States Government has certain rights in the invention.
- The present invention provides methods and apparatuses for incubating and washing magnetically responsive beads on a droplet actuator. More specifically the present invention provides methods for incubating magnetically responsive beads that are labeled with primary antibody, a sample (i.e., analyte), and secondary reporter antibodies on a magnet, on and off a magnet, and completely off a magnet. The invention also provides methods for washing magnetically responsive beads using shape-assisted merging of droplets. The invention also provides methods for shape-mediated splitting, transporting, and dispensing of a sample droplet that contains magnetically responsive beads. The methods of the invention provide for rapid time to result and optimum detection of an analyte in an immunoassay.
- Droplet actuators are used to conduct a wide variety of droplet operations. A droplet actuator typically includes two substrates separated by a gap. The substrates include electrodes for conducting droplet operations. The gap between the substrates is typically filled with a filler fluid that is immiscible with the fluid that is to be subjected to droplet operations. Droplet operations are controlled by electrodes associated with one or both of the substrates. Droplet actuators are used in a variety of applications, including molecular diagnostic assays, such as immunoassays where time to result is directly affected by the protocols used for each step of the assay. The most time consuming steps in an immunoassay are incubation and washing. “Time to result” is directly affected by the protocols used for incubation, the duration of time for incubating the antibodies and the antigens, and the duration of time for incubating the substrate with sandwich beads, all of which may depend on the mixing efficiency within the droplets and the reaction and binding kinetics. The amount of washing required to obtain the required sensitivity may also influence the total time to result for immunoassays. There is a need for efficient incubation and washing protocols for immunoassays on a droplet actuator that provide for rapid time to result and optimum detection of an analyte.
- The present invention is directed to bead incubation and washing on a droplet actuator. The methods described herein may include providing a droplet including one or more magnetically responsive beads. The methods may include exposing the magnetically responsive beads in the droplet to a first region of a magnetic field capable of substantially attracting magnetically responsive beads in the droplet. The methods may include separating the droplet from the first region of the magnetic field, the magnetically responsive beads remaining in the magnetic field. The magnetically responsive beads may be separated from the droplet while exposing the magnetically responsive beads in the droplet to a first region of a magnetic field and/or while the droplet is being separated from the first region of the magnetic field. Exposing the magnetically responsive beads in the droplet to a first region of a magnetic field may include transporting the droplet into the first region of the magnetic field and/or transporting the first region of the magnetic field into proximity with the magnetically responsive beads. Separating the droplet from the first region of the magnetic field may include transporting the droplet away from the first region of the magnetic field and/or moving the first region of the magnetic field away from the droplet.
- In one embodiment, a method of incubating droplets having magnetically responsive beads is provided and comprises providing a droplet actuator comprising droplet operations electrodes arranged for conducting droplet operations on a droplet operations surface and a magnet positioned relative to the droplet operations surface such that a droplet controlled by one or more of the droplet operations electrodes may be positioned within or away from a first region of the magnet's magnetic field capable of substantially attracting magnetically responsive beads in the droplet. The method also comprises positioning a droplet having magnetically responsive beads therein at a location on the droplet operations surface within the first region of the magnetic field to form a concentration of beads in the droplet; transporting the droplet through activation of selected droplet operations electrodes away from the first region of the magnetic field, thereby resuspending the magnetically responsive beads in the droplet; operating the droplet operations electrodes to cause the droplet to split into two droplets, thereby redistributing the magnetically responsive beads; and operating the droplet operations electrodes to merge the two droplets into a single droplet.
- In another embodiment, a method of incubating droplets having magnetically responsive beads therein is provided and comprises providing a droplet actuator comprising droplet operations electrodes arranged for conducting droplet operations on a droplet operations surface and a magnet positioned relative to the droplet operations surface such that a droplet controlled by one or more of the droplet operations electrodes may be positioned within or away from a first region of the magnet's magnetic field capable of substantially attracting magnetically responsive beads in the droplet. The method also comprises positioning a droplet having magnetically responsive beads therein at a location within the first region of the magnetic field of the magnet to form a concentration of beads in the droplet; transporting the droplet through activation of selected droplet operations electrodes away from the first region of the magnetic field of the magnet to resuspend the magnetically responsive beads in the droplet; operating the droplet operations electrodes to cause the droplet to elongate and then split into two droplets at a location away from the magnet; and operating the droplet operations electrodes to merge the two droplets into a single droplet at a location away from the magnet, whereby the transporting, splitting, and merging comprise an incubation cycle.
- In yet another embodiment, a method of incubating droplets having magnetically responsive beads therein is provided and comprises providing a droplet actuator comprising droplet operations electrodes arranged for conducting droplet operations on a droplet operations surface and a magnet positioned relative to the droplet operations surface such that a droplet controlled by one or more of the droplet operations electrodes may be positioned within or away from a first region of the magnet's magnetic field capable of substantially attracting magnetically responsive beads in the droplet. The method further comprises positioning a droplet having magnetically responsive beads therein on a droplet operations electrode, the droplet having a footprint approximately two times the area of a single droplet operations electrode; transporting the droplet through activation of selected droplet operations electrodes in one direction in a manner elongating the droplet; and operating the droplet operations electrodes in a manner to cause the droplet to be transported in an opposite direction to cause mixing and incubation within the droplet.
- In a further embodiment, a method of washing magnetically responsive beads for separating and removing unbound material is provided and comprises providing a droplet actuator comprising droplet operations electrodes arranged for conducting droplet operations on a droplet operations surface and a magnet positioned relative to the droplet operations surface such that a droplet controlled by one or more of the droplet operations electrodes may be positioned within or away from a first region of the magnet's magnetic field capable of substantially attracting magnetically responsive beads in the droplet. The method further comprises positioning a droplet having magnetically responsive beads therein to have a first region of the droplet within the first region of the magnetic field to form a concentration of beads; at another end of the magnetic field, positioning a wash buffer droplet such that a first region of the wash buffer droplet is within the first region of the magnetic field; operating the droplet operations electrodes to merge the droplet and the wash droplet to cause redistribution of beads; operating the droplet operation electrodes to cause the merged droplet to partially move away from the magnet, and to cause beads in the droplet to concentrate in the merged droplet; and operating the droplet operations electrodes to split the merged droplet to form a supernatant droplet containing unbound reagents.
- In a still further embodiment, a method of resuspending magnetically responsive beads between wash cycles is provided and comprises providing a droplet actuator comprising droplet operations electrodes arranged for conducting droplet operations on a droplet operations surface and a magnet positioned relative to the droplet operations surface such that a droplet controlled by one or more of the droplet operations electrodes may be positioned within or away from a first region of the magnet's magnetic field capable of substantially attracting magnetically responsive beads in the droplet. The method further comprises positioning a droplet having magnetically responsive beads therein at a location partially overlapping the first region of the magnetic field; transporting the droplet through activation of selected droplet operations electrodes away from the first region of the magnetic field; operating the droplet operations electrodes to cause the droplet to move towards the first region of the magnetic field; and repeating the transporting and operating steps to cause sufficient resuspension of beads such that unbound material may be effectively removed in subsequent wash cycles.
- In another embodiment, a droplet actuator device having a structure for conducting a bead washing protocol is provided and comprises an array of droplet operations electrodes configured to provide a plurality of individual wash lanes, and a single waste lane intersecting each one of the plurality of wash lanes; and waste wells associated at the end of each one of the plurality of wash lanes, and at the end of the single waste lane.
- In yet another embodiment, a method of separating magnetically responsive beads from a droplet is provided and comprises providing a droplet actuator comprising droplet operations electrodes arranged for conducting droplet operations on a droplet operations surface and a magnet positioned relative to the droplet operations surface such that a droplet controlled by one or more of the droplet operations electrodes may be positioned within or away from a first region of the magnet's magnetic field capable of substantially attracting magnetically responsive beads in the droplet. The method further comprises positioning a droplet having magnetically responsive beads therein within the first region of the magnetic field of the magnet to cause the magnetically responsive beads to be attracted to the magnet, and activating the droplet operations surface to cause the droplet to be circular in shape; operating the droplet operations surface to cause the droplet to move away from the first region of the magnetic field to form a concentration of magnetically responsive beads in the droplet, and the droplet operations surface being operated to cause the droplet to be transported away from the magnet one droplet operations electrode at a time, to cause the geometry of the droplet to be distorted; and continuing to transport the droplet away from the magnet to cause the concentration of magnetically responsive beads to break away from the droplet to result in a relatively small and highly concentrated magnetically responsive bead droplet left behind and held immobilized by the magnet.
- In a further embodiment, a method of transporting magnetically responsive beads within droplets is provided and comprises providing a droplet actuator comprising droplet operations electrodes arranged for conducting droplet operations on a droplet operations surface and a magnet positioned relative to the droplet operations surface such that a droplet controlled by one or more of the droplet operations electrodes may be positioned within or away from a first region of the magnet's magnetic field capable of substantially attracting magnetically responsive beads in the droplet. The method further comprises positioning a droplet having magnetically responsive beads located therein at a location wherein the droplet partially overlaps the magnet; operating the droplet operations electrodes to subject an edge of the droplet nearest the magnet to both a magnetic force from the first region of the magnetic field and an electrowetting force from the droplet operations electrodes, and to subject an edge of the droplet furthest from the magnet only to an electrowetting force, to cause the droplet to be transported away from the magnet while retaining the magnetically responsive beads within the droplet; and continuing to transport the droplet away from the magnet to cause the magnetically responsive beads to be redistributed within the droplet.
- In a still further embodiment, a method of separating beads from a droplet onto a magnet is provided and comprises providing a droplet actuator comprising droplet operations electrodes arranged for conducting droplet operations on a droplet operations surface and a magnet positioned relative to the droplet operations surface such that a droplet controlled by one or more of the droplet operations electrodes may be positioned within or away from a first region of the magnet's magnetic field capable of substantially attracting magnetically responsive beads in the droplet. The method further comprises positioning a droplet having magnetically responsive beads therein within the first region of the magnetic field of the magnet to cause the beads to be attracted to the magnet, and activating the droplet operations surface in a manner to cause the droplet to take an elongate shape; operating the droplet operations surface to activate one electrode at a time, to cause the droplet to move away from the magnet, and thereby cause the geometry of the droplet to be distorted; and continuing to operate the droplet operations surface to transport the droplet further away from the magnet and inactivating an electrode intermediate to the droplet to cause the droplet to split into a supernatant droplet and a smaller droplet that has the magnetically responsive beads therein.
- In another embodiment, a droplet actuator structure for extracting DNA from a sample is provided and comprises at least six on-actuator reservoirs interconnected for storing and dispensing different reagents onto the droplet actuator; and the reservoirs interconnected through paths of droplet operations electrodes, including at least two paths having magnets associated therewith, and a bead collection reservoir connected to the six on-actuator reservoirs through the droplet operations electrodes paths.
- In yet another embodiment, a method of extracting DNA from whole blood is provided and comprises using a droplet actuator comprising at least six on-actuator reservoirs interconnected for storing and dispensing different reagents onto the droplet actuator; and the reservoirs interconnected through paths of droplet operations electrodes, including at least two paths having magnets associated therewith, and a bead collection reservoir connected to the six on-actuator reservoirs through the droplet operations electrodes paths. The method further comprises dispensing a droplet of magnetically responsive beads suspended in a lysis buffer from a first of the six on-actuator reservoirs, and transporting the droplet through the droplet operations electrodes to a specific location having one of the magnets associated with the location, to hold the magnetically responsive beads within the droplet thereon; dispensing droplets of whole blood from a second reservoir and lysis buffer from a third reservoir into a fourth mixing reservoir to be mixed therein to form a cell lysate; dispensing droplets of the cell lysate across the magnetically responsive beads in succession and removing supernatant from the droplets while holding the magnetically responsive beads; dispensing wash droplets from at least a fifth reservoir to wash the magnetically responsive beads to remove cell debris; and eluting and collecting DNA captured on the magnetically responsive beads at the bead collection reservoir.
- In a further embodiment, a method of detecting a component in a sample is provided and comprises providing a droplet actuator comprising droplet operations electrodes arranged for conducting droplet operations on a droplet operations surface; a magnet positioned related to the droplet operations surface such that a droplet controlled by one of more droplet operations electrodes may be positioned within or away from a first region of the magnet's magnetic field capable of substantially attracting magnetically responsive beads in the droplet; and a wash reservoir at one end of the arrangement of droplet operations electrodes. The method further comprises positioning a droplet having magnetically responsive beads located therein, the magnetically responsive beads being coated with an antibody having an affinity for a specific target antigen, away from the magnet; operating the droplet operations surface in a manner to repeatedly transport the droplet back and forth, away from the magnet, in a manner to provide sufficient resuspension and mixing of the magnetically responsive beads for antibody and antigen binding; operating the droplet operations surface in a manner to transport the droplet to a location within the first region of the magnetic field, and splitting off a supernatant droplet from the droplet by selectively operating the droplet operations surface, and retaining the magnetically responsive beads at the magnet; operating the droplet operations electrodes to transport a reagent droplet to the droplet operations electrode in the first region of the magnetic field to merge the reagent droplet with the droplet containing the magnetically responsive beads, and transporting the merged droplet back and forth, at a location away from the magnet, to cause incubation; and transporting the merged droplet through operation of the droplet operations electrodes to the droplet operations electrode at the magnet and splitting off a supernatant droplet through operation of the droplet operations electrodes.
- As used herein, the following terms have the meanings indicated.
- “Activate” with reference to one or more electrodes means effecting a change in the electrical state of the one or more electrodes which results in a droplet operation.
- “Bead,” with respect to beads on a droplet actuator, means any bead or particle that is capable of interacting with a droplet on or in proximity with a droplet actuator. Beads may be any of a wide variety of shapes, such as spherical, generally spherical, egg shaped, disc shaped, cubical and other three dimensional shapes. The bead may, for example, be capable of being transported in a droplet on a droplet actuator or otherwise configured with respect to a droplet actuator in a manner which permits a droplet on the droplet actuator to be brought into contact with the bead, on the droplet actuator and/or off the droplet actuator.
- Beads may be manufactured using a wide variety of materials, including for example, resins, and polymers. The beads may be any suitable size, including for example, microbeads, microparticles, nanobeads and nanoparticles. In some cases, beads are magnetically responsive; in other cases beads are not significantly magnetically responsive. For magnetically responsive beads, the magnetically responsive material may constitute substantially all of a bead or one component only of a bead. The remainder of the bead may include, among other things, polymeric material, coatings, and moieties which permit attachment of an assay reagent. Examples of suitable magnetically responsive beads are described in U.S. Patent Publication No. 2005-0260686, entitled, “Multiplex flow assays preferably with magnetic particles as solid phase,” published on Nov. 24, 2005, the entire disclosure of which is incorporated herein by reference for its teaching concerning magnetically responsive materials and beads. The fluids may include one or more magnetically responsive and/or non-magnetically responsive beads. Examples of droplet actuator techniques for immobilizing magnetically responsive beads and/or non-magnetically responsive beads and/or conducting droplet operations protocols using beads are described in U.S. patent application Ser. No. 11/639,566, entitled “Droplet-Based Particle Sorting,” filed on Dec. 15, 2006; U.S. Patent Application No. 61/039,183, entitled “Multiplexing Bead Detection in a Single Droplet,” filed on Mar. 25, 2008; U.S. Patent Application No. 61/047,789, entitled “Droplet Actuator Devices and Droplet Operations Using Beads,” filed on Apr. 25, 2008; U.S. Patent Application No. 61/086,183, entitled “Droplet Actuator Devices and Methods for Manipulating Beads,” filed on Aug. 5, 2008; International Patent Application No. PCT/US2008/053545, entitled “Droplet Actuator Devices and Methods Employing Magnetic Beads,” filed on Feb. 11, 2008; International Patent Application No. PCT/US2008/058018, entitled “Bead-based Multiplexed Analytical Methods and Instrumentation,” filed on Mar. 24, 2008; International Patent Application No. PCT/US2008/058047, “Bead Sorting on a Droplet Actuator,” filed on Mar. 23, 2008; and International Patent Application No. PCT/US2006/047486, entitled “Droplet-based Biochemistry,” filed on Dec. 11, 2006; the entire disclosures of which are incorporated herein by reference.
- “Droplet” means a volume of liquid on a droplet actuator that is at least partially bounded by filler fluid. For example, a droplet may be completely surrounded by filler fluid or may be bounded by filler fluid and one or more surfaces of the droplet actuator. Droplets may, for example, be aqueous or non-aqueous or may be mixtures or emulsions including aqueous and non-aqueous components. Droplets may take a wide variety of shapes; nonlimiting examples include generally disc shaped, slug shaped, truncated sphere, ellipsoid, spherical, partially compressed sphere, hemispherical, ovoid, cylindrical, and various shapes formed during droplet operations, such as merging or splitting or formed as a result of contact of such shapes with one or more surfaces of a droplet actuator.
- “Droplet Actuator” means a device for manipulating droplets. For examples of droplets, see U.S. Pat. No. 6,911,132, entitled “Apparatus for Manipulating Droplets by Electrowetting-Based Techniques,” issued on Jun. 28, 2005 to Pamula et al.; U.S. patent application Ser. No. 11/343,284, entitled “Apparatuses and Methods for Manipulating Droplets on a Printed Circuit Board,” filed on filed on Jan. 30, 2006; U.S. Pat. No. 6,773,566, entitled “Electrostatic Actuators for Microfluidics and Methods for Using Same,” issued on Aug. 10, 2004 and U.S. Pat. No. 6,565,727, entitled “Actuators for Microfluidics Without Moving Parts,” issued on Jan. 24, 2000, both to Shenderov et al.; Pollack et al., International Patent Application No. PCT/US2006/047486, entitled “Droplet-Based Biochemistry,” filed on Dec. 11, 2006, the disclosures of which are incorporated herein by reference. Methods of the invention may be executed using droplet actuator systems, e.g., as described in International Patent Application No. PCT/US2007/009379, entitled “Droplet manipulation systems,” filed on May 9, 2007. In various embodiments, the manipulation of droplets by a droplet actuator may be electrode mediated, e.g., electrowetting mediated or dielectrophoresis mediated.
- “Droplet operation” means any manipulation of a droplet on a droplet actuator. A droplet operation may, for example, include: loading a droplet into the droplet actuator; dispensing one or more droplets from a source droplet; splitting, separating or dividing a droplet into two or more droplets; transporting a droplet from one location to another in any direction; merging or combining two or more droplets into a single droplet; diluting a droplet; mixing a droplet; agitating a droplet; deforming a droplet; retaining a droplet in position; incubating a droplet; heating a droplet; vaporizing a droplet; condensing a droplet from a vapor; cooling a droplet; disposing of a droplet; transporting a droplet out of a droplet actuator; other droplet operations described herein; and/or any combination of the foregoing. The terms “merge,” “merging,” “combine,” “combining” and the like are used to describe the creation of one droplet from two or more droplets. It should be understood that when such a term is used in reference to two or more droplets, any combination of droplet operations sufficient to result in the combination of the two or more droplets into one droplet may be used. For example, “merging droplet A with droplet B,” can be achieved by transporting droplet A into contact with a stationary droplet B, transporting droplet B into contact with a stationary droplet A, or transporting droplets A and B into contact with each other. The terms “splitting,” “separating” and “dividing” are not intended to imply any particular outcome with respect to size of the resulting droplets (i.e., the size of the resulting droplets can be the same or different) or number of resulting droplets (the number of resulting droplets may be 2, 3, 4, 5 or more). The term “mixing” refers to droplet operations which result in more homogenous distribution of one or more components within a droplet. Examples of “loading” droplet operations include microdialysis loading, pressure assisted loading, robotic loading, passive loading, and pipette loading. In various embodiments, the droplet operations may be electrode mediated, e.g., electrowetting mediated or dielectrophoresis mediated.
- “Filler fluid” means a fluid associated with a droplet operations substrate of a droplet actuator, which fluid is sufficiently immiscible with a droplet phase to render the droplet phase subject to electrode-mediated droplet operations. The filler fluid may, for example, be a low-viscosity oil, such as silicone oil. Other examples of filler fluids are provided in International Patent Application No. PCT/US2006/047486, entitled, “Droplet-Based Biochemistry,” filed on Dec. 11, 2006; and in International Patent Application No. PCT/US2008/072604, entitled “Use of additives for enhancing droplet actuation,” filed on Aug. 8, 2008.
- “Immobilize” with respect to magnetically responsive beads, means that the beads are substantially restrained in position in a droplet or in filler fluid on a droplet actuator. For example, in one embodiment, immobilized beads are sufficiently restrained in position to permit execution of a splitting operation on a droplet, yielding one droplet with substantially all of the beads and one droplet substantially lacking in the beads.
- “Magnetically responsive” means responsive to a magnetic field. “Magnetically responsive beads” include or are composed of magnetically responsive materials. Examples of magnetically responsive materials include paramagnetic materials, ferromagnetic materials, ferrimagnetic materials, and metamagnetic materials. Examples of suitable paramagnetic materials include iron, nickel, and cobalt, as well as metal oxides, such as Fe3O4, BaFe12O19, CoO, NiO, Mn2O3, Cr2O3, and CoMnP.
- “Washing” with respect to washing a magnetically responsive bead means reducing the amount and/or concentration of one or more substances in contact with the magnetically responsive bead or exposed to the magnetically responsive bead from a droplet in contact with the magnetically responsive bead. The reduction in the amount and/or concentration of the substance may be partial, substantially complete, or even complete. The substance may be any of a wide variety of substances; examples include target substances for further analysis, and unwanted substances, such as components of a sample, contaminants, and/or excess reagent. In some embodiments, a washing operation begins with a starting droplet in contact with a magnetically responsive bead, where the droplet includes an initial amount and initial concentration of a substance. The washing operation may proceed using a variety of droplet operations. The washing operation may yield a droplet including the magnetically responsive bead, where the droplet has a total amount and/or concentration of the substance which is less than the initial amount and/or concentration of the substance. Other embodiments are described elsewhere herein, and still others will be immediately apparent in view of the present disclosure.
- The terms “top” and “bottom” are used throughout the description with reference to the top and bottom substrates of the droplet actuator for convenience only, since the droplet actuator is functional regardless of its position in space.
- “Transporting into the magnetic field of a magnet,” “transporting towards a magnet,” and the like, as used herein to refer to droplets and/or magnetically responsive beads within droplets, is intended to refer to transporting into a region of a magnetic field capable of substantially attracting magnetically responsive beads in the droplet. Similarly, “transporting away from a magnet or magnetic field,” “transporting out of the magnetic field of a magnet,” and the like, as used herein to refer to droplets and/or magnetically responsive beads within droplets, is intended to refer to transporting away from a region of a magnetic field capable of substantially attracting magnetically responsive beads in the droplet, whether or not the droplet or magnetically responsive beads is completely removed from the magnetic field. It will be appreciated that in any of such cases described herein, the droplet may be transported towards or away from the desired region of the magnetic field, and/or the desired region of the magnetic field may be moved towards or away from the droplet. Reference to an electrode, a droplet, or magnetically responsive beads being “within” or “in” a magnetic field, or the like, is intended to describe a situation in which the electrode is situated in a manner which permits the electrode to transport a droplet into and/or away from a desired region of a magnetic field, or the droplet or magnetically responsive beads is/are situated in a desired region of the magnetic field, in each case where the magnetic field in the desired region is capable of substantially attracting any magnetically responsive beads in the droplet. Similarly, reference to an electrode, a droplet, or magnetically responsive beads being “outside of” or “away from” a magnetic field, and the like, is intended to describe a situation in which the electrode is situated in a manner which permits the electrode to transport a droplet away from a certain region of a magnetic field, or the droplet or magnetically responsive beads is/are situated away from a certain region of the magnetic field, in each case where the magnetic field in such region is capable of substantially attracting any magnetically responsive beads in the droplet.
- When a liquid in any form (e.g., a droplet or a continuous body, whether movingor stationary) is described as being “on”, “at”, or “over” an electrode, array, matrix or surface, such liquid could be either in direct contact with the electrode/array/matrix/surface, or could be in contact with one or more layers or films that are interposed between the liquid and the electrode/array/matrix/surface.
- When a droplet is described as being “on” or “loaded on” a droplet actuator, it should be understood that the droplet is arranged on the droplet actuator in a manner which facilitates using the droplet actuator to conduct one or more droplet operations on the droplet, the droplet is arranged on the droplet actuator in a manner which facilitates sensing of a property of or a signal from the droplet, and/or the droplet has been subjected to a droplet operation on the droplet actuator.
-
FIGS. 1A, 1B, 1C, 1D, and 1E illustrate top views of an example of a region of a droplet actuator and show a process of incubating beads on a magnet; -
FIGS. 2A, 2B, 2C, 2D, and 2E illustrate top views of an example of a region of a droplet actuator ofFIGS. 1A through 1E and show a process of incubating droplets that include magnetically responsive beads on and off a magnet; -
FIGS. 3A, 3B, 3C, 3D, and 3E illustrate top views of an example of a region of a droplet actuator and show a process of incubating droplets that include magnetically responsive beads completely off a magnet; -
FIG. 4 shows a plot of a comparison of incubation time between on-magnet and off-magnet incubation protocols ofFIG. 1 andFIG. 2 , respectively, on immunoassay performance measured in chemiluminescence; -
FIGS. 5A, 5B, 5C, 5D, and 5E show a top view of a region of a droplet actuator and a process of washing magnetically responsive beads using shape-assisted merging of droplets; -
FIG. 6 shows a plot of a comparison of washing protocols between slug shaped and circular shaped wash droplets on immunoassay performance measured in chemiluminescence; -
FIGS. 7A, 7B, 7C, and 7D illustrate top views of an example of a region of a droplet actuator ofFIGS. 5A through 5E and show a process of resuspending magnetically responsive beads between wash cycles; -
FIGS. 8A and 8B show plots of a comparison of washing protocols ofFIG. 5 without resuspension cycles and with resuspension cycles, respectively; -
FIG. 9 illustrates a top view of a region of adroplet actuator 900 that includes multiple waste wells; -
FIGS. 10A, 10B, and 10C show a top view of a region of a droplet actuator and a process of separating beads from a sample droplet; -
FIGS. 11A, 11B, and 11C show a top view of a region of a droplet actuator ofFIGS. 10A through 10C and a process of transporting beads within a droplet; -
FIGS. 12A, 12B, and 12C show a top view of a region of a droplet actuator ofFIGS. 10A through 10C and another process of separating beads from a sample droplet onto a magnet; -
FIGS. 13A and 13B show a comparison of bench top and droplet actuator immunoassay reagent ratios and a plot of reagent concentration versus signal strength, respectively, that provide for optimum droplet based immunoassay performance; -
FIG. 14 shows a plot of the kinetics of a reaction between a chemiluminescent substrate and ALP reporter on magnetically responsive beads for Troponin I (TnI); -
FIG. 15 is a top view of a droplet actuator that may be used for extracting DNA from a whole blood sample; -
FIGS. 16A and 16B illustrate top views of an example of a portion of a droplet actuator and show a process of cytokine detection on a droplet actuator; -
FIG. 17 shows a plot of two 5-point standard curves for cytokine IL-6; and -
FIG. 18 shows a plot of two 6-point standard curves for cytokine TNF-α. - The present invention provides methods and apparatuses for incubating and washing magnetically responsive beads on a droplet actuator. More specifically the present invention provides methods for incubating magnetically responsive beads that are labeled with primary antibody, a sample (i.e., analyte), and secondary reporter antibodies on a magnet, on and off a magnet, and completely off a magnet. The invention also provides methods for washing magnetically responsive beads using shape-assisted merging of droplets. The invention also provides methods for shape-mediated splitting, transporting, and dispensing of a sample droplet that contains magnetically responsive beads. The methods of the invention provide for rapid time to result and optimum detection of an analyte in an immunoassay.
- In an alternative embodiment of the invention, a droplet actuator may be used to extract human genomic DNA from a sample.
- Incubation protocols on a droplet actuator are generally comprised of transporting a droplet (e.g., a droplet that includes an antigen, primary capture antibodies conjugated to magnetically responsive beads, and secondary reporter antibodies) along a path of electrodes by use of splitting and merging operations that are inserted between transport cycles. Transporting, splitting, and merging the droplet ensures that the beads are well distributed (i.e., mixed) within the droplet. An incubation cycle (e.g., transport, split, and merge) may be repeated two or more times. The high mixing efficiency provided by a series of incubation cycles provides for sufficient antigen-antibody binding.
- Magnetically responsive beads have a tendency to settle and form aggregates due to gravity and/or continued exposure to strong magnetic forces. These aggregates reduce the available surface area for binding and slow down reaction kinetics and, consequently, the time to result and sensitivity of the assay. Moreover, interstices in magnetically responsive bead aggregates can hold unbound species that leads to ineffective washing. This may result in less sensitive assays and inaccuracies between assays due to differing amounts of unbound species held in the interstices. Therefore, it is useful to keep the beads dispersed or resuspended during incubation and in the steps immediately following separation for further processing of the droplets away from the magnets. Resuspension of magnetically responsive beads within droplets, akin to rigorous vortexing of bench scale systems, may be achieved by moving the bead droplet back and forth and exploiting the inherent circulatory flow patterns that are developed during droplet transport.
-
FIGS. 1A, 1B, 1C, 1D, and 1E illustrate top views of an example of a region of adroplet actuator 100 and show a process of incubating droplets that include magnetically responsive beads on a magnet. The method of the invention ofFIGS. 1A through 1E is an example of an incubation method wherein a droplet is transported into the magnetic field of a magnet and a series of split and merge droplet operations are performed to resuspend the beads within the droplet. Because of the magnet field, resuspension of the beads is primarily in the X-Y direction. -
Droplet actuator 100 may include a path or array of droplet operations electrodes 110 (e.g., electrowetting electrodes). Amagnet 114 is arranged in close proximity todroplet operations electrodes 110. In particular,magnet 114 is arranged such that certain droplet operations electrodes 100 (e.g., 3droplet operations electrodes 110M) are within the magnetic field ofmagnet 114.Magnet 114 may, for example, be a permanent magnet or an electromagnet.Droplet actuator 100 may contain adroplet 118 that may be transported alongdroplet operations electrodes 110 via electrowetting and upon which droplet operations may be performed.Droplet 118 may, for example, be a 3× droplet, meaning that its footprint is approximately 3 times the area of one droplet operations electrode 110.Droplet 118 may, for example, include 1 part magnetically responsive beads and 2 parts sample.Droplet 118 may, for example, be a sample droplet that includes an analyte (e.g., an antigen) to be evaluated. -
Droplet 118 may include one ormore beads 122, which may be magnetically responsive beads.Beads 122 may have an affinity for certain target substances, such as, for example, a certain type of cell, protein, nucleic acid and/or antigen. In one example,beads 122 are coated with a primary antibody with affinity for a specific target antigen. -
FIG. 1A shows a first step in a process of incubating droplets that includes magnetically responsive beads on a magnet. In this step,droplet 118 that hasbeads 122 therein is positioned adjacent to and overlappingdroplet operations electrodes 110M, which is within the magnetic field ofmagnet 114. Becausebeads 122 are magnetically responsive, a concentration of beads is formed at the side ofdroplet 118 that is closest tomagnet 114. -
FIG. 1B shows another step in the process of incubating droplets that include magnetically responsive beads on a magnet. In this step,droplet 118 is transported via electrowetting toadjacent electrodes 110M and takes on a slug-shaped geometry. Typically, twodroplet operations electrodes 110 may be used to transport a 3×droplet 118. Becausebeads 122 are magnetically responsive, a concentration ofbeads 122 is formed at the bottom of droplet 118 (e.g., on the surface of droplet actuator 100) and at the center ofmagnet 114. Elongation ofdroplet 118 to a slug geometry provides for sufficient flow of fluid withindroplet 118 to resuspendbeads 122 indroplet 118. -
FIG. 1C shows yet another step in the process of incubating droplets that include magnetically responsive beads on a magnet. In this step,droplet 118 is split near the central region ofmagnet 114 using droplet operations to form, for example, two sample droplets. Splitting ofdroplet 118 provides for redistribution ofbeads 122 within the sample droplets. -
FIG. 1D shows yet another step in the process of incubating droplets that include magnetically responsive beads on a magnet. In this step, splitdroplet 118 is merged onmagnet 114 using droplet operations to form asingle droplet 118. The transporting, splitting, and merging operations ofFIGS. 1B, 1C, and 1D comprise an incubation cycle. Several incubation cycles may be performed to provide for resuspension and redistribution (i.e., mixing) ofbeads 122 indroplet 118. -
FIG. 1E shows yet another step in the process of incubating droplets that include magnetically responsive beads on a magnet. In this step,magnet 114, which is, for example, an electromagnet, is not activated. Therefore, no magnetic field is generated bymagnet 114 andbeads 122 ofdroplet 118 have no attraction tomagnet 114.Droplet 118 is transported via electrowetting toadjacent electrodes 110.Beads 122 are resuspended indroplet 118. -
FIGS. 2A, 2B, 2C, 2D, and 2E illustrate top views of an example of a region of adroplet actuator 100 ofFIGS. 1A through 1E and show a process of incubating, on and off a magnet, droplets that include magnetically responsive beads. The method of the invention ofFIGS. 2A through 2E is an example of an incubation method wherein a droplet is transported near the magnetic field of a magnet and then away from the magnet to perform a series of split and merge droplet operations that are used to resuspend the beads within the droplet. Because the split and merge operations are performed away from the magnet, resuspension of the beads is in the lateral X-Y, and vertical Z directions. - The steps shown in
FIGS. 2A, 2B, 2C, 2D, and 2E are substantially the same as those that are described inFIGS. 1A, 1B, 1C, 1D, and 1E except that, instead of incubatingdroplet 118 ondroplet operations electrodes 110M, droplet incubation is performed adjacent tomagnet 114 and away frommagnet 114 ondroplet operations electrodes 110. -
FIG. 2A shows a first step in a process of incubating droplets that include magnetically responsive beads on and off a magnet. In this step,droplet 118 that hasbeads 122 therein is positioned adjacent todroplet operations electrodes 110M, which is within the magnetic field ofmagnet 114. Becausebeads 122 are magnetically responsive, a concentration of beads is formed at the side ofdroplet 118 that is closest tomagnet 114. -
FIG. 2B shows another step in a process of incubating, on and off a magnet, droplets that include magnetically responsive beads. In this step,droplet 118 is transported via electrowetting away from the magnetic field ofmagnet 114.Beads 122 are sufficiently resuspended indroplet 118. -
FIG. 2C, 2D, and 2E show the process steps of droplet elongation (i.e., formation of slug-shaped geometry), droplet splitting and droplet merging, respectively, that are used to provide for sufficient flow of fluid withindroplet 118 to resuspend and redistributebeads 122 indroplet 118. Because the split and merge operations are performed away from the magnet, resuspension of the beads is in the X, Y, and Z directions. -
FIGS. 3A, 3B, 3C, 3D, and 3E illustrate top views of an example of a region of adroplet actuator 300 and show a process of incubating droplets that include magnetically responsive beads substantially out of the magnetic field of a magnet. The method of the invention ofFIGS. 3A through 3E is an example of an incubation method wherein a series of droplet transport operations are used to resuspend the beads within the droplet. Because the droplet operations are performed a sufficient distance away from a magnet, resuspension of the beads is in the lateral X-Y, and vertical Z directions. -
Droplet actuator 300 is substantially the same asdroplet actuator 100 ofFIGS. 1A through 1E except that it is configured to support droplet operations on a 2× droplet. In this embodiment,droplet 118 is a 2× droplet, meaning that its footprint is approximately 2 times the area of one droplet operations electrode.Droplet 118 may, for example, include 1 part magnetically responsive beads and 1 part sample. Alternatively,droplet 118 may include 1 part sample plus magnetically responsive beads and 1 part secondary reporter antibody. -
FIGS. 3A through 3E show the process steps of transportingdroplet 118 along a linear path ofdroplet operation electrodes 110 to provide mixing of magneticallyresponsive beads 122. The use of a 2× droplet provides several advantages over the use of a 3× droplet in a droplet actuator-based immunoassay. For example, mixing a 2× droplet using two droplet operations electrodes is more efficient than mixing a 3× droplet using two droplet operations electrodes. The concentration of magnetically responsive beads is also higher in a 2× droplet than a 3× droplet. A higher concentration of magnetically responsive beads provides for increased binding rate. Because the incubation cycle of a 2× droplet is substantially out of the magnetic field ofmagnet 114, the binding efficiency is also increased. In addition, transport of a 3× droplet in proximity to a magnetic field via electrowetting using 2 droplet operation electrodes may result in the formation of a tail in which magnetically responsive beads may aggregate. The formation of bead aggregates may result in reduced binding efficiency. -
FIG. 4 shows aplot 400 of a comparison of incubation time between on-magnet and off-magnet incubation protocols on immunoassay performance measured in chemiluminescence. Data was generated using the incubation protocols ofFIG. 1 (on-magnet) andFIG. 2 (off-magnet). Immunoassays were performed on a 300 nanoliter (nL) droplet that contained capture antibody magnetically responsive beads, alkaline phosphatase (ALP)-labeled reporter antibodies and 5 ng/mL Troponin I (TnI). Four immunoassays were performed on the magnet with incubation times of 72 seconds (sec), 198 sec, 450 sec, and 630 sec. Four more immunoassays were performed off the magnet with incubation times of 90 sec, 180 sec, 252 sec, and 324 sec. Droplet operations were the same for each incubation protocol. - As shown in
FIG. 4 , when incubation was performed on the magnet, the time to reach saturation was almost doubled the time to reach saturation when compared to incubation performed off the magnet. The difference in time to reach saturation between the two protocols may occur because in the presence of a magnet, the magnetically responsive beads are attracted to the surface of the droplet actuator and the recirculation patterns produce within a droplet would resuspend the magnetically responsive beads only in the lateral plane (X-Y) direction. When incubation is performed off the magnet and a sufficient distance away from the magnet (e.g., more than 2 droplet operations electrodes), resuspension of the magnetically responsive beads is in both the lateral plane (X-Y direction) and vertical plane (Z direction). Resuspension of the beads in the X, Y, and Z directions provides more surface area for binding reactions and increased rate of reaction. - In another embodiment, an incubation protocol may include merging of a circular bead droplet on a magnet with two circular sample droplets. Mixing in the merged droplet is provided by moving the merged droplet back and forth on droplet operations electrodes while the magnetically responsive beads are immobilized on the magnet.
- In yet another embodiment, an incubation protocol may include merging of a circular bead droplet on a magnet with a 4×, 5× elongated (slug-shaped) sample droplet. Mixing in the merged slug-shaped droplet is provided by moving the merged droplet back and forth on droplet operations electrodes while the magnetically responsive beads are immobilized on the magnet.
- Washing of magnetically responsive beads, where unbound molecules are separated and removed, is one of the most critical steps in implementing an immunoassay in a digital microfluidic system. In some embodiments, washing is performed using a merge-and-split protocol, which is repeated until the unbound material is sufficiently depleted from the supernatant to permit accurate and precise detection.
-
FIGS. 5A, 5B, 5C, 5D, and 5E show a top view of a region of adroplet actuator 500 and a process of washing magnetically responsive beads using shape-assisted merging of droplets. The method of the invention ofFIGS. 5A through 5E is an example of a wash method wherein a wash buffer droplet and a magnetically responsive bead droplet are elongated in a slug-shaped geometry and series of merge and split operations are used to remove unbound material from a bead droplet. The merge and split operations provide for substantially complete fluid replacement of unbound supernatant with wash buffer in the absence of mixing. -
Droplet actuator 500 may include a path or array of droplet operations electrodes 510 (e.g., electrowetting electrodes). Amagnet 512 is arranged in close proximity todroplet operations electrodes 510. In particular,magnet 512 is arranged such that certain droplet operations electrodes 510 (e.g., 3droplet operations electrodes 510M) are within the magnetic field ofmagnet 512.Magnet 512 may, for example, be a permanent magnet or an electromagnet.Droplet actuator 500 may contain awash buffer droplet 516 and abead droplet 514 that may be transported alongdroplet operations electrodes 510 via electrowetting and upon which droplet operations may be performed.Bead droplet 514 may, for example, include a quantity of magneticallyresponsive beads 518 that includes bound antigen and reporter antibody (i.e., antigen-antibody-reporter complex), and unbound material such as excess unbound reporter antibody. -
Bead droplet 514 and washbuffer droplet 516 may, for example, be 2× droplets, meaning that their footprint is approximately 2 times the area of one droplet operations electrode 510.Bead droplet 514 and washbuffer droplet 516 may be configured as slug-shaped droplets (i.e., elongated droplets) by performing droplet operations on the 2× droplets using two activedroplet operations electrodes 510. Because the excess droplet volume is now spread over a second active droplet operations electrode 510, the droplets are elongated and conform to the shape of two electrodes. -
FIG. 5A shows a first step in a process of washing beads using shape-assisted merging of droplets. In this step,bead droplet 514 that hasbeads 518 therein is positioned such that one region ofdroplet 514 is on adroplet operations electrodes 510M which is within the magnetic field ofmagnet 512 and a second region ofdroplet 514 is on an adjacent droplet operations electrode 510. Becausebeads 518 are magnetically responsive, a concentration of beads is formed at the side ofbead droplet 514 that is closest tomagnet 512. At the opposite end ofmagnet 512, washbuffer droplet 516 is similarly positioned such that one region ofwash buffer droplet 516 is on adroplet operations electrodes 510M which is within the magnetic field ofmagnet 512 and a second region ofdroplet 516 is on an adjacent droplet operations electrode 510. The timing of the sequence of droplet operations for mergingbead droplet 514 and washbuffer 516 is such thatbead droplet 514 is elongated to a slug-shaped geometry just as wash buffer droplet is positioned via electrowetting for merging withbead droplet 514. -
FIGS. 5B shows another step in a process of washing beads using shape-assisted merging of droplets. In this step,bead droplet 514 and washeddroplet 516 are merged. Merging ofbead droplet 514 and washdroplet 516 provides for redistribution ofbeads 518. -
FIGS. 5C and 5D show another step in a process of washing beads using shape-assisted merging of droplets. In this step, a slug offluid 520 is extended away frommagnet 512 by activating the contiguousdroplet operations electrodes 510 and inactivating the intermediatedroplet operations electrodes 510 outside the magnetic field ofmagnet 512.Fluid 520 includes wash buffer fromwash buffer droplet 516 and unbound reagents frombead droplet 514. Asfluid 520 is extended,beads 518 remain concentrated onmagnet 512. -
FIG. 5E shows yet another step in a process of washing beads using shape-assisted merging of droplets. In this step, a fluid 520 is split using droplet operations to formsupernatant droplet 522.Supernatant droplet 522 includes unbound reagents such as unbound reporter antibody frombead droplet 514.Supernatant droplet 522 is typically discarded in a waste well (not shown).FIGS. 5A through 5E show the set of droplet operations that comprise a wash cycle. Several wash cycles may be performed to provide for sufficient removal of unbound material. - In an alternative embodiment, a washing protocol may use a wash droplet and a bead droplet that are circular in shape. A circular shape of a droplet may, for example, be obtained by performing droplet operations on a 2× wash droplet and a 2× bead droplet using only one droplet operations electrode each. Because a 2× droplet (i.e., footprint is approximately 2 times the area of one droplet operations electrode) is much larger than a single droplet operations electrode, the droplet takes a more rounded shape.
-
FIG. 6 shows aplot 600 of a comparison of washing protocols between slug shaped and circular shaped wash droplets on immunoassay performance measured in chemiluminescence. In both protocols, incubation was performed using the off-magnet incubation protocol ofFIG. 2 for 3 minutes. Each wash cycle takes about 10 seconds in a slug-based protocol ofFIG. 5 and about 14 seconds in a circular droplet protocol. - As shown is
FIG. 6 , a washing protocol performed using slugs of fluid (or elongated droplets as shown inFIG. 5 ), wherein a 2× wash buffer droplet and a 2× bead droplet were operated using two electrodes, a sufficient wash level was achieved using fewer wash cycles when compared to washing using circular shaped droplets. In a slug-based washing protocol, mixing was minimized and the bulk of the unbound material from the supernatant was replaced with fresh wash buffer at each cycle. In a circular-droplet based protocol, mixing was ensured by operating the 2× droplets using only one electrode each. Also, the dispersion of magnetically responsive beads in the lateral plane (X-Y direction) was higher in the slug-based protocol when a fresh wash buffer droplet was merged with a bead droplet. Greater dispersion of magnetically responsive beads in the merged droplet enables any unbound antibody trapped in the interstices to diffuse into the supernatant and be washed away in subsequent washes. In this example, sufficient wash levels were achieved in about 10 wash cycles using a slug-based washing protocol compared to >18 wash cycles in a circular droplet based wash protocol. - The washing behavior has two distinct regimes, one regime where washing may be very pronounced and the second where the washing may be subtle. In the slug based washing case, the washing is pronounced with each wash cycle up to about 9 cycles and after that the effect of washing is almost negligible. In the circular droplet protocol, the washing effect is pronounced until about the 15th wash; although the wash efficiency is less than that observed for the slug-based protocol. Washing is only marginally effective for the circular droplet protocol between about the 15th and 18th washes with only a slight reduction in signal with each cycle. This could happen because all the free unbound material may be washed away in the first few cycles and after that washing only removes the unbound material trapped between the beads.
-
FIGS. 7A, 7B, 7C, and 7D illustrate top views of an example of a region of adroplet actuator 500 ofFIGS. 5A through 5E and show a process of resuspending magnetically responsive beads between wash cycles. The method of the invention ofFIGS. 7A through 7D is an example of a sequence in a wash method that uses a series of droplet resuspension cycles to resuspend the magnetically responsive beads between wash cycles such as a wash cycle shown inFIG. 5 . The resuspension cycles provide sufficient resuspension of the beads such that unbound material from the interstices of bead aggregates may be effectively removed. -
FIG. 7A shows the first step in a process of resuspending magnetically responsive beads between wash cycles. In this step,bead droplet 514 that includes magneticallyresponsive beads 518 is transported via electrowetting away frommagnet 512 in the direction of arrow A. -
FIGS. 7B, 7C, and 7D show the process steps of transportingbead droplet 514 along a path ofdroplet operation electrodes 510 in the direction of arrow A. Three transport operations are shown inFIGS. 7B, 7C, and 7D , but any number of transport operations may be used to comprise a resuspension cycle. Transporting ofbead droplet 514 provides for sufficient resuspension ofbeads 518 such that unbound material from the interstices of bead aggregates may be effectively removed in subsequent wash cycles. - A complete wash protocol may include a series of wash cycles, such as the slug based wash cycles of
FIG. 5 , interspersed with a one or more resuspension cycles ofFIG. 7 . Depending on the sensitivity of the assay required and the time to result requirement, any number of wash cycles may be interspersed with any number of resuspension cycles. For example, a complete wash protocol sequence may include, for example, four wash cycles, four resuspension cycles, and four wash cycles. A complete wash protocol sequence ends at a wash cycle. -
FIGS. 8A and 8B show plots of a comparison of washing protocols ofFIG. 5 without resuspension cycles and with resuspension cycles, respectively. As shown inFIG. 8A , a washing protocol in the absence of one or more resuspension cycles provides an initial drop in signal after a number of wash cycles (A). As the number of wash cycles increase (B), there is a further reduction in signal that may be due to loss of unbound material from the interstices of bead aggregates. - As shown in
FIG. 8B , a washing protocol that includes one or more resuspension cycles provides more efficient removal of unbound material to a near zero level using fewer numbers of wash cycles (A). -
FIG. 9 illustrates a top view of a region of adroplet actuator 900 that includes multiple waste wells. In this embodiment, multiple waste wells are provided to improve the efficiency (e.g., time to result) of a bead washing protocol such as a bead washing protocol shown inFIG. 5 . - As illustrated,
droplet actuator 900 includes an array of droplet operations electrodes 910 (e.g., electrowetting electrodes) configured to providewash lanes single waste lane 916. Washlanes magnets waste wells Waste lane 916 may include awaste well 918. - In operation,
droplet actuator 900 may be used to conduct a bead washing protocol on four different samples inwash lanes 912 a through 912 d. In a bead washing protocol, the supernatant droplet(s) that contain unbound material, such as unbound antigen and secondary reporter antibody, is typically discarded in a waste well. In one example, a bead washing protocol may use asingle waste well 918. In this example, asingle waste lane 916 that includes waste well 918 may be used to transport supernatant (i.e., waste) droplets fromwash lanes 912 a through 912 d. - In this example, supernatant (i.e., waste) droplets from
wash lanes 912 a through 912 d may be transported via electrowetting in the direction of Arrow A to washlane 916. Individual supernatant droplets may then be transported inwaste lane 916 in the direction of Arrow B to waste well 918. Becausewaste lane 916 is common to washlanes 912 a through 912 d, supernatant droplets must be transported serially (i.e., one after another). - In an alternative example,
individual waste wells 920 a through 920 d may be provided for eachwash lane 912 a through 912 d, respectively. In this example, supernatant droplets may be transported simultaneously in the direction of arrow C toindividual waste wells 920 a through 920 d. Multiple, individual waste wells provide for increased efficiency (e.g., time to result) in a washing protocol. Multiple waste wells also provide for a reduction in the number ofdroplet operations electrodes 910 that are required to shuttle a supernatant droplet to a waste well. A reduction in the number ofoperations electrodes 910 that may be used to transport a supernatant droplet also provides for a reduction in the potential for cross-contamination of subsequent droplets used in a protocol. -
FIGS. 10A, 10B, and 10C show a top view of a region of adroplet actuator 1000 and a process of separating beads from a sample droplet. The method of the invention ofFIGS. 10A through 10C is an example of a method wherein magnetically responsive beads are split from a circular shaped droplet. -
Droplet actuator 1000 may include a path or array of droplet operations electrodes 1010 (e.g., electrowetting electrodes). Amagnet 1014 is arranged in close proximity todroplet operations electrodes 1010. In particular,magnet 1014 is arranged such that certain droplet operations electrodes 1010 (e.g., 3droplet operations electrodes 1010M) are within the magnetic field ofmagnet 1014.Magnet 1014 may, for example, be a permanent magnet or an electromagnet. -
Droplet actuator 1000 may contain adroplet 1016 that may be transported alongdroplet operations electrodes 1010 via electrowetting and upon which droplet operations may be performed.Droplet 1016 may include a quantity ofbeads 1020, which may be magnetically responsive beads. An example of a process of separating beads from a circular droplet may include, but is not limited to, the following steps. -
FIG. 10A shows a first step in a process of separating beads from a circular droplet. In this step,droplet 1016 that hasbeads 1020 therein is positioned at adroplet operations electrode 1010M, which is within the magnetic field ofmagnet 1014. Becausebeads 1020 are magnetically responsive,beads 1020 are attracted tomagnet 1014. Because a singledroplet operations electrode 1010M is active,droplet 1016 is circular in shape. -
FIG. 10B shows another step in a process of separating beads from a circular droplet. In this step,droplet 1016 is transported via electrowetting away fromdroplet operations electrode 1010M and to the adjacentdroplet operations electrode 1010. Asdroplet 1016 moves away fromdroplet operations electrode 1010M, a concentration ofbeads 1020 is formed at the side ofdroplet 1016 that is closest tomagnet 1014. Becausedroplet 1016 is transported away frommagnet 1014 one droplet operations electrode 1010 at a time, the geometry ofdroplet 1016 may be distorted (e.g., formation of a neck) by the concentration ofbeads 1020 asdroplet 1016 pulls away frommagnet 1020. -
FIG. 10C shows yet another step in the process of separating beads from a circular droplet. In this step,droplet 1016 is transported via electrowetting further away fromdroplet operations electrode 1010M and to a droplet operations electrode 1010 that is yet further away. In doing so, the concentration ofbeads 1020 breaks away (snaps off) fromdroplet 1016. This occurs because one side (e.g., the side nearest magnet 1014) ofdroplet 1016 is subjected to a magnetic force and the opposite side (e.g., the side farthest from magnet 1014) is subjected to electrowetting force. Whenbeads 1020 snap off ofdroplet 1016, a relatively small and highlyconcentrated bead droplet 1022 is left behind atdroplet operations electrode 1010M and held immobilized bymagnet 1014. - A similar result can be achieved using a barrier that permits a bead-containing droplet to be transported while restraining transport of the beads with the main body of the droplet.
-
FIGS. 11A, 11B, and 11C show a top view of a region of adroplet actuator 1000 ofFIGS. 10A through 10C and a process of transporting beads within a droplet. The method of the invention ofFIGS. 11A through 11C is an example of a method wherein magnetically responsive beads are transported within an elongated droplet away from a magnetic force. - The steps shown in
FIGS. 11A, 11B, and 11C are substantially the same as those that are described inFIGS. 10A, 10B, and 10C except that, instead of processing a 1× droplet via electrowetting using one active electrode at a time,droplet 1016 is a slug-shaped 3× droplet that is processed using three active electrodes for each droplet operation. -
FIGS. 11A, 11B, and 11C show the process steps of transportingbeads 1020 within anelongated droplet 1016 away frommagnet 1014. In this example, one side (e.g., the side nearest magnet 1014) ofdroplet 1016 is subjected to both a magnetic force and electrowetting force and the opposite side (e.g., the side farthest from magnet 1014) is subjected to electrowetting force. Because electrowetting force occurs on both sides ofdroplet 1016, all of the fluid within the droplet is electrowetted andbeads 1020 are retained withindroplet 1016 during droplet transport away frommagnet 1014. -
FIGS. 12A, 12B, and 12C show a top view of a region of adroplet actuator 1000 and a process of separating beads from a sample droplet onto a magnet. The method of the invention ofFIGS. 12A through 12C is an example of a method wherein magnetically responsive beads are split from an elongated droplet (e.g., 3× droplet) onto a magnet. In one example, the method of the invention ofFIGS. 12A through 12C may be used to dispense magnetically responsive beads onto a magnet. - The steps shown in
FIGS. 12A, 12B, and 12C are substantially the same as those that are described inFIGS. 10A, 10B, and 10C except that,beads 1020 are split from an elongated 3×droplet 1016. An example of a process of dispensing beads from an elongated droplet may include, but is not limited to, the following steps. -
FIG. 12A shows a first step in a process of dispensing beads from an elongated droplet. In this step,droplet 1016 that hasbeads 1020 therein is positioned at adroplet operations electrode 1010M, which is within the magnetic field ofmagnet 1014. Becausebeads 1020 are magnetically responsive,beads 1020 are attracted tomagnet 1014. Because threedroplet operations electrodes 1010 are active,droplet 1016 is elongated in shape. -
FIG. 12B shows another step in a process of dispensing beads from an elongated droplet. In this step,droplet 1016 is transported away frommagnet 1014 via electrowetting using one active droplet operations electrode 1010 at a time. Asdroplet 1016 moves away fromdroplet operations electrode 1010M, a concentration ofbeads 1020 is formed at the side ofdroplet 1016 that is closest tomagnet 1014. Becausedroplet 1016 is transported away frommagnet 1014 one droplet operations electrode 1010 at a time, the geometry ofdroplet 1016 may be distorted. -
FIG. 12C shows yet another step in process of dispensing beads from an elongated droplet. In this step,droplet 1016 is transported via electrowetting further away fromdroplet operations electrode 1010M and to a droplet operations electrode 1010 that is yet further away. Once the sample droplet overlaps thedroplet operation electrode 1010 on whichdroplet 1022 is to be formed, theintermediate electrode 1010 is deactivated. In doing so,droplet 1016 is split into asupernatant droplet 1022 and asmaller droplet 1016 that hasbeads 1020 therein. -
FIGS. 13A and 13B show a comparison of bench top and droplet actuator immunoassay reagent ratios and a plot of reagent concentration versus signal strength, respectively, that provide for optimum droplet based immunoassay performance. - As shown in
FIG. 13A , the ratio of three components of an immunoassay, beads (i.e., capture antibody conjugated to beads), sample (e.g., serum, plasma), and secondary antibody (II° Ab) are provided. For a bench top immunoassay, a typical ratio is 1 part beads (60 μL): ½ part sample (30 μL): 1 part II° Ab (60 μL). A reagent ratio for a droplet actuator based immunoassay is typically ½ bead droplet (150 nL): 1 sample droplet (300 nL): 2 II° Ab droplets (600 nL). The use of fewer beads (i.e., ½ bead droplet or ½ concentration of beads) in a droplet actuator immunoassay provides for increased efficiency of bead washing and a sufficient reduction in non-specific binding of non-target analytes to the capture beads. In addition, the concentration of secondary antibody is the same in both bench top and droplet actuator immunoassays, but the volume of secondary antibody solution is double in the droplet actuator assay. -
FIG. 13B shows the improvement in detection signal that is provided by the use of 2 droplets of secondary antibody and 2 droplets of detection substrate in a droplet actuator immunoassay. - Another parameter which may influence the time to result in an immunoassay is the generation of a signal during the incubation of a chemiluminescent substrate with the washed magnetically responsive beads that contain the antigen-antibody complex.
-
FIG. 14 shows aplot 1400 of the kinetics of a reaction between a chemiluminescent substrate and the ALP on magnetically responsive beads for Troponin I (TnI). Immunoassays were performed on TnI (100 ng/mL) using an on-magnet incubation protocol and a circular shaped droplet washing protocol. As shown inFIG. 14 , about 90% of the end point signal was obtained in about 120 to about 130 seconds. For a lower concentration of the analyte, maximum signal was achieved in about <120 seconds. Based on this data, for the type of substrate used, 2 minutes may be selected as an optimum incubation time to generate maximum signal for the chemiluminescence reaction. However, if the chemiluminescence reaction is observed to behave as a flash signal instead of a glow reaction, the 2 minute incubation may be reduced to about a few seconds. - Using optimized protocols for incubation and washing, a full immunoassay was performed on TnI (5 ng/mL). Magnetically responsive beads were incubated with capture antibody, analyte and secondary antibody labeled with ALP reporter using an off-magnet incubation protocol as shown in
FIG. 3 . Subsequently, ten slugbased washes were performed to remove the unbound material from the supernatant (wash time approximately 2 minutes). The droplet with washed magnetically responsive beads with the antigen-antibody complex was mixed with one droplet of a chemiluminescent substrate and incubated for 2 minutes. The end point chemiluminescence was detected using a photon counter. In this example, the total time to result was approximately 10 minutes per immunoassay. -
FIG. 15 is a top view of adroplet actuator 1500 that may be used for extracting DNA from a whole blood sample. Thedroplet actuator 1500 includes six on-actuator reservoirs, each with a capacity of 2 μL, which may be used for storing and dispensing different reagents. A typical protocol for DNA extraction on a droplet actuator may include the following steps. - In a first step, a droplet of magnetically responsive beads, such as paramagnetic Dynabeads® DNA Direct Universal from Dynal Biotech (1.05 μm diameter), suspended in a lysis buffer are dispensed from an on-chip reservoir and transported via electrowetting to a specific location on the chip. The beads, which are magnetically responsive, are held by a permanent magnet placed underneath the chip.
- In another step, droplets of whole blood are dispensed from a reservoir and mixed with droplets of lysis buffer (containing 10 M NaOH) dispensed from another onchip reservoir, into a mixing reservoir in the ratio of 1:6 and mixed for about 10 seconds. Mixing was performed by dispensing a droplet and then merging the droplet back into the reservoir.
- In another step, droplets of the cell lysate were then transported across the DNA capture beads in succession and the supernatant was pinched off while holding the beads.
- In another step, droplets of wash buffer stored in separate on-chip reservoirs were then used to wash the beads to remove cell debris.
- In another step, purified genomic DNA captured on the beads was then eluted and collected at the bead collection reservoir. The collected DNA can then be amplified either on the chip as part of an integrated sample-to-answer chip or in a commercial thermocycler for further DNA processing or diagnostic applications.
- For examples of fluids that may be subjected to droplet operations using the approach of the invention, see the patents listed in
section 6, especially International Patent Application No. PCT/US2006/047486, entitled, “DropletBased Biochemistry,” filed on Dec. 11, 2006. In some embodiments, the fluid includes a biological sample, such as whole blood, lymphatic fluid, serum, plasma, sweat, tear, saliva, sputum, cerebrospinal fluid, amniotic fluid, seminal fluid, vaginal excretion, serous fluid, synovial fluid, pericardial fluid, peritoneal fluid, pleural fluid, transudates, exudates, cystic fluid, bile, urine, gastric fluid, intestinal fluid, fecal samples, fluidized tissues, fluidized organisms, biological swabs, biological washes, liquids with cells, tissues, multicellular organisms, single cellular organisms, protozoa, bacteria, fungal cells, viral particles, organelles. In some embodiments, the fluid includes a reagent, such as water, deionized water, saline solutions, acidic solutions, basic solutions, detergent solutions and/or buffers. In some embodiments, the fluid includes a reagent, such as a reagent for a biochemical protocol, such as a nucleic acid amplification protocol, an affinity-based assay protocol, a sequencing protocol, and/or a protocol for analyses of biological fluids. - The fluids may include one or more magnetically responsive and/or nonmagnetically responsive beads. Examples of droplet actuator techniques for immobilizing magnetically responsive beads and/or non-magnetically responsive beads are described in the foregoing international patent applications and in Sista, et al., U.S. Patent Application No. 60/900,653, entitled “Immobilization of Magnetically-responsive Beads During Droplet Operations,” filed on Feb. 9, 2007; Sista et al., U.S. Patent Application No. 60/969,736, entitled “Droplet Actuator Assay Improvements,” filed on Sep. 4, 2007; and Allen et al., U.S. Patent Application No. 60/957,717, entitled “Bead Washing Using Physical Barriers,” filed on Aug. 24, 2007, the entire disclosures of which is incorporated herein by reference.
-
FIGS. 16A and 16B illustrate top views of an example of a portion of adroplet actuator 1600 and show a process of cytokine detection on a droplet actuator. All steps involved in the immunoassay, including sample and reagent aliquoting, incubation with antibodies, bead washing, and enzymatic detection, are fully automated and under software control. -
Droplet actuator 1600 may include a path or array of droplet operations electrodes 1610 (e.g., electrowetting electrodes) and awash reservoir 1612. Amagnet 1614 is arranged in close proximity todroplet operations electrodes 1610. In particular,magnet 1614 is arranged such that a certain droplet operations electrode 1610 (e.g.,droplet operations electrode 1610M) is within the magnetic field thereof.Magnet 1614 may be a permanent magnet or an electromagnet.Droplet actuator 1600 may contain adroplet 1618 that may be transported alongdroplet operations electrodes 1610 and upon which droplet operations may be performed. -
Droplet 1618 may, for example, be a 3× droplet, meaning that its footprint is approximately 3 times the area of onedroplet operations electrode 1610.Droplet 1618 may, for example, include 1 part magnetically responsive beads and 2 parts sample (e.g., an antigen to be evaluated). -
Droplet 1618 may include one or more magneticallyresponsive beads 1622. Magneticallyresponsive beads 1622 are coated with a primary antibody that has an affinity for a specific target antigen. In one example, magneticallyresponsive beads 1622 are coated with a primary antibody that has an affinity for IL-6. In another example, magneticallyresponsive beads 1622 are coated with a primary antibody that has an affinity for TNF-α. - An example of a process of cytokine detection on a droplet actuator may include, but is not limited to, the following steps:
- Step A of
FIG. 16A shows adroplet 1618 that has magneticallyresponsive beads 1622 therein and is positioned at a certaindroplet operations electrode 1610. In one example,droplet 1618 includes 1part beads - Steps B and C of
FIG. 16A show an incubation process, in which droplet 1618 is repeatedly transported back and forth via droplet operations toadjacent electrodes 1610. Repeated transporting ofdroplet 1618 is used during incubation ofbeads 1622 and sample in order to provide sufficient resuspension and mixing of magneticallyresponsive beads 1622 for optimal antibody and antigen binding. Typically, twodroplet operations electrodes 1610 may be used to transport a 3×droplet 1618, which takes on a slug shaped geometry. Elongation ofdroplet 1618 to a slug shape provides for sufficient flow of fluid withindroplet 1618 to resuspend magneticallyresponsive beads 1622 therein. In one example,droplet 1618 may be incubated for 6 minutes using 2droplet operations electrodes 1610 and transportingdroplet 1618 over a span of 8 electrodes at a switching speed of 5 Hertz (Hz). - Step D of
FIG. 16A showsdroplet 1618 that has magneticallyresponsive beads 1622 therein transported todroplet operations electrode 1610M. Asupernatant droplet 1624 is split off using droplet operations. Because magneticallyresponsive beads 1622 are attracted tomagnet 1614, they are retained atmagnet 1614. In one example,supernatant droplet 1624 is a 1× droplet anddroplet 1618 is now a 2× droplet.Supernatant droplet 1624 that includes unbound antigen (i.e., cytokine) is discarded (not shown). - Step E of
FIG. 16A shows areagent droplet 1628 that includes secondary antibody transported via electrowetting todroplet operations electrode 1610M.Reagent droplet 1628 is merged with droplet 1618 (i.e., a 2× droplet) using droplet operations to form, for example, a 3× droplet. - In one example,
reagent droplet 1628 is a 1× droplet that includes biotinylated secondary antibody that has an affinity to the target antigen. The antigen target is captured by the primary antibody which is immobilized on the beads.Merged droplet 1618 is incubated for 4 minutes using droplet operations, as described in steps B and C. Following the incubation period,droplet 1618 is transported via electrowetting todroplet operations electrode 1610M and a 1× supernatant droplet is split off using droplet operations, as described in step D, in order to yield a 2×droplet 1618. The supernatant droplet (not shown) that includes unbound secondary antibody is discarded. - After incubation with the biotinylated secondary antibody, the beads may in some embodiments be washed and then incubated with the streptavidin-peroxidase. The entire complex thus consists of beads-primary antibody-antigen-secondary antibody-streptavidin-peroxidase. Streptavidin-peroxidase may be substituted with streptavidin-alkaline phosphatase.
- Step F of
FIG. 16B shows a bead washing step, in which awash droplet 1630 is transported fromwash reservoir 1612 alongdroplet operations electrodes 1610 and acrossdroplet 1618, which is retained atdroplet operations electrode 1610M. Aswash droplet 1630 passes acrossmagnet 1614, droplet merge and split operations occur with droplet 1618 (i.e., a 2× droplet). In one example, washdroplet 1630 is a 2× droplet that has a slug geometry and the washing protocol is repeated 5 times. Following bead washing, a 1× supernatant droplet is split off fromdroplet 1618, as described in step D ofFIG. 16A , in order to yield a 1×droplet 1618. The supernatant droplet (not shown) is discarded. - Step G of
FIG. 16B shows one or more reagent droplets 1632 (e.g., 1632 a, 1632 b) transported todroplet operations electrode 1610M. In one example,reagent droplet 1632 a that includes a blocking agent (e.g., Synblock) andreagent droplet 1632 b that includes a streptavidin-enzyme conjugate (e.g., streptavidinalkaline phosphatase (ALP) or streptavidin-horseradish peroxidase) are transported todroplet operations electrode 1610M and merged using droplet operations withdroplet 1618.Droplet 1618 is now a 3× droplet. -
Merged droplet 1618 is incubated for 4 minutes using droplet operations, as described in steps B and C ofFIG. 16A . Following the incubation period,droplet 1618 is transported todroplet operations electrode 1610M and a supernatant droplet (i.e., a 1× droplet) is split off using droplet operations, as described in step D ofFIG. 16A , in order to yield a 2×droplet 1618. The supernatant droplet (not shown) that includes unbound streptavidin-enzyme conjugate is discarded. -
Droplet 1618 is subsequently washed, for example 15 times, as described in step F ofFIG. 16B . Following bead washing, a 1× supernatant droplet is split offdroplet 1618, as described in step D ofFIG. 16A , in order to yield a 1×droplet 1618. The supernatant droplet (not shown) is discarded.Droplet 1618 that includes antibody-antigen sandwich is now ready for detection. - Step H of
FIG. 16B shows droplet 1634 (1× droplet) that includes adetection substrate 1636 transported todroplet operations electrode 1610M and merged using droplet operations withdroplet 1618. Thedetection substrate 1636 is converted by the enzyme conjugate into a fluorescent signal (product formation time about 1620 seconds). The chemiluminescent signal is measured by a detector (not shown) in order to determine the quantity of antigen that is present. - In some embodiments, wash buffer droplets may be transported across the detection window following each chemiluminescent droplet to clean up the detection window and the detection loop prior to the next detection.
- In one embodiment, the method of the invention is used to detect IL-6.
FIG. 17 shows a plot of two 5-point standard curves for cytokine IL-6. Data was generated using the cytokine detection protocol described inFIGS. 16A and 16B . In this example, two 5-point standard curves (0, 0.05, 0.5, 5, and 25 ng/mL of IL-6) were obtained in 2 runs for IL-6 performed on 2 separate droplet actuators. - In an alternative embodiment, the method of the invention is used to detect TNF-α.
FIG. 18 shows a plot of two 6-point standard curves for cytokine TNF-α. Data was generated using the cytokine detection protocol described inFIGS. 16A and 16B . In this example, two 6-point standard curves (0, 0.01, 0.1, 1, 10, and 100 ng/mL of TNF-α) were obtained in 2 runs for TNF-αperformed on 2 separate droplet actuators. - The foregoing detailed description of embodiments refers to the accompanying drawings, which illustrate specific embodiments of the invention. Other embodiments having different structures and operations do not depart from the scope of the present invention. The term “the invention” or the like is used with reference to certain specific examples of the many alternative aspects or embodiments of the applicants' invention set forth in this specification, and neither its use nor its absence is intended to limit the scope of the applicants' invention or the scope of the claims. This specification is divided into sections for the convenience of the reader only. Headings should not be construed as limiting of the scope of the invention. The definitions are intended as a part of the description of the invention. It will be understood that various details of the present invention may be changed without departing from the scope of the present invention. Furthermore, the foregoing description is for the purpose of illustration only, and not for the purpose of limitation.
Claims (3)
1. A droplet actuator comprising:
(i) droplet operations electrodes to conduct droplet operations on a droplet operations surface; and
(ii) a magnet positioned relative to the droplet operations surface such that a droplet controlled by one or more of the droplet operations electrodes may be positioned within or away from a first region of the magnet's magnetic field to attract magnetically responsive beads in the droplet;
wherein the magnet is positioned such that three or more droplet operations electrodes are within the magnetic field of the magnet.
2. The method of claim 1 , wherein the magnet is an electromagnet.
3. The method of claim 1 , wherein the magnetically responsive beads are coated with a primary antibody with an affinity for a specific target antigen.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/063,874 US20230128722A1 (en) | 2006-04-18 | 2022-12-09 | Bead incubation and washing on a droplet actuator |
Applications Claiming Priority (26)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74503906P | 2006-04-18 | 2006-04-18 | |
US74505906P | 2006-04-18 | 2006-04-18 | |
US74505806P | 2006-04-18 | 2006-04-18 | |
US74504306P | 2006-04-18 | 2006-04-18 | |
US74595006P | 2006-04-28 | 2006-04-28 | |
US74591406P | 2006-04-28 | 2006-04-28 | |
US74679706P | 2006-05-09 | 2006-05-09 | |
US74680106P | 2006-05-09 | 2006-05-09 | |
US80641206P | 2006-06-30 | 2006-06-30 | |
US80710406P | 2006-07-12 | 2006-07-12 | |
US11/639,736 US7439014B2 (en) | 2006-04-18 | 2006-12-15 | Droplet-based surface modification and washing |
US11/639,531 US8613889B2 (en) | 2006-04-13 | 2006-12-15 | Droplet-based washing |
US12/113,385 US8541176B2 (en) | 2006-04-18 | 2008-05-01 | Droplet-based surface modification and washing |
US10330208P | 2008-10-07 | 2008-10-07 | |
US12279108P | 2008-12-16 | 2008-12-16 | |
PCT/US2009/059868 WO2010042637A2 (en) | 2008-10-07 | 2009-10-07 | Bead incubation and washing on a droplet actuator |
US12/615,609 US8313895B2 (en) | 2006-04-18 | 2009-11-10 | Droplet-based surface modification and washing |
US12/615,666 US8951721B2 (en) | 2006-04-18 | 2009-11-10 | Droplet-based surface modification and washing |
US13/081,927 US8637324B2 (en) | 2006-04-18 | 2011-04-07 | Bead incubation and washing on a droplet actuator |
US14/081,376 US8846410B2 (en) | 2006-04-18 | 2013-11-15 | Bead incubation and washing on a droplet actuator |
US14/466,193 US9081007B2 (en) | 2006-04-18 | 2014-08-22 | Bead incubation and washing on a droplet actuator |
US14/731,740 US9395361B2 (en) | 2006-04-18 | 2015-06-05 | Bead incubation and washing on a droplet actuator |
US15/210,634 US10078078B2 (en) | 2006-04-18 | 2016-07-14 | Bead incubation and washing on a droplet actuator |
US16/132,175 US10585090B2 (en) | 2006-04-18 | 2018-09-14 | Bead incubation and washing on a droplet actuator |
US16/811,789 US11525827B2 (en) | 2006-04-18 | 2020-03-06 | Bead incubation and washing on a droplet actuator |
US18/063,874 US20230128722A1 (en) | 2006-04-18 | 2022-12-09 | Bead incubation and washing on a droplet actuator |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/811,789 Continuation US11525827B2 (en) | 2006-04-18 | 2020-03-06 | Bead incubation and washing on a droplet actuator |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230128722A1 true US20230128722A1 (en) | 2023-04-27 |
Family
ID=44475579
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/081,927 Active US8637324B2 (en) | 2006-04-18 | 2011-04-07 | Bead incubation and washing on a droplet actuator |
US14/081,376 Active US8846410B2 (en) | 2006-04-18 | 2013-11-15 | Bead incubation and washing on a droplet actuator |
US14/466,193 Active US9081007B2 (en) | 2006-04-18 | 2014-08-22 | Bead incubation and washing on a droplet actuator |
US14/731,740 Active US9395361B2 (en) | 2006-04-18 | 2015-06-05 | Bead incubation and washing on a droplet actuator |
US18/063,874 Pending US20230128722A1 (en) | 2006-04-18 | 2022-12-09 | Bead incubation and washing on a droplet actuator |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/081,927 Active US8637324B2 (en) | 2006-04-18 | 2011-04-07 | Bead incubation and washing on a droplet actuator |
US14/081,376 Active US8846410B2 (en) | 2006-04-18 | 2013-11-15 | Bead incubation and washing on a droplet actuator |
US14/466,193 Active US9081007B2 (en) | 2006-04-18 | 2014-08-22 | Bead incubation and washing on a droplet actuator |
US14/731,740 Active US9395361B2 (en) | 2006-04-18 | 2015-06-05 | Bead incubation and washing on a droplet actuator |
Country Status (1)
Country | Link |
---|---|
US (5) | US8637324B2 (en) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101198038B1 (en) | 2005-01-28 | 2012-11-06 | 듀크 유니버서티 | Apparatuses and methods for manipulating droplets on a printed circuit board |
CA2606750C (en) | 2005-05-11 | 2015-11-24 | Nanolytics, Inc. | Method and device for conducting biochemical or chemical reactions at multiple temperatures |
US20140193807A1 (en) | 2006-04-18 | 2014-07-10 | Advanced Liquid Logic, Inc. | Bead manipulation techniques |
US9476856B2 (en) | 2006-04-13 | 2016-10-25 | Advanced Liquid Logic, Inc. | Droplet-based affinity assays |
US7439014B2 (en) * | 2006-04-18 | 2008-10-21 | Advanced Liquid Logic, Inc. | Droplet-based surface modification and washing |
US8716015B2 (en) | 2006-04-18 | 2014-05-06 | Advanced Liquid Logic, Inc. | Manipulation of cells on a droplet actuator |
WO2007123908A2 (en) | 2006-04-18 | 2007-11-01 | Advanced Liquid Logic, Inc. | Droplet-based multiwell operations |
US8637324B2 (en) | 2006-04-18 | 2014-01-28 | Advanced Liquid Logic, Inc. | Bead incubation and washing on a droplet actuator |
US10078078B2 (en) | 2006-04-18 | 2018-09-18 | Advanced Liquid Logic, Inc. | Bead incubation and washing on a droplet actuator |
US8389297B2 (en) | 2006-04-18 | 2013-03-05 | Duke University | Droplet-based affinity assay device and system |
US8927296B2 (en) | 2006-04-18 | 2015-01-06 | Advanced Liquid Logic, Inc. | Method of reducing liquid volume surrounding beads |
US8980198B2 (en) | 2006-04-18 | 2015-03-17 | Advanced Liquid Logic, Inc. | Filler fluids for droplet operations |
US8809068B2 (en) | 2006-04-18 | 2014-08-19 | Advanced Liquid Logic, Inc. | Manipulation of beads in droplets and methods for manipulating droplets |
US7901947B2 (en) | 2006-04-18 | 2011-03-08 | Advanced Liquid Logic, Inc. | Droplet-based particle sorting |
US9675972B2 (en) | 2006-05-09 | 2017-06-13 | Advanced Liquid Logic, Inc. | Method of concentrating beads in a droplet |
ES2423930T3 (en) | 2007-02-09 | 2013-09-25 | Advanced Liquid Logic, Inc. | Droplet actuator devices and methods using magnetic beads |
EP2109774B1 (en) | 2007-02-15 | 2018-07-04 | Advanced Liquid Logic, Inc. | Capacitance detection in a droplet actuator |
WO2008116209A1 (en) | 2007-03-22 | 2008-09-25 | Advanced Liquid Logic, Inc. | Enzymatic assays for a droplet actuator |
WO2009002920A1 (en) | 2007-06-22 | 2008-12-31 | Advanced Liquid Logic, Inc. | Droplet-based nucleic acid amplification in a temperature gradient |
US8702938B2 (en) | 2007-09-04 | 2014-04-22 | Advanced Liquid Logic, Inc. | Droplet actuator with improved top substrate |
WO2013006312A2 (en) | 2011-07-06 | 2013-01-10 | Advanced Liquid Logic Inc | Reagent storage on a droplet actuator |
AU2008345138B2 (en) | 2007-12-23 | 2014-05-29 | Advanced Liquid Logic, Inc. | Droplet actuator configurations and methods of conducting droplet operations |
WO2009137415A2 (en) | 2008-05-03 | 2009-11-12 | Advanced Liquid Logic, Inc. | Reagent and sample preparation, loading, and storage |
US8877512B2 (en) | 2009-01-23 | 2014-11-04 | Advanced Liquid Logic, Inc. | Bubble formation techniques using physical or chemical features to retain a gas bubble within a droplet actuator |
US8926065B2 (en) | 2009-08-14 | 2015-01-06 | Advanced Liquid Logic, Inc. | Droplet actuator devices and methods |
US9091649B2 (en) | 2009-11-06 | 2015-07-28 | Advanced Liquid Logic, Inc. | Integrated droplet actuator for gel; electrophoresis and molecular analysis |
EP2516669B1 (en) | 2009-12-21 | 2016-10-12 | Advanced Liquid Logic, Inc. | Enzyme assays on a droplet actuator |
US9248450B2 (en) | 2010-03-30 | 2016-02-02 | Advanced Liquid Logic, Inc. | Droplet operations platform |
WO2011137533A1 (en) | 2010-05-05 | 2011-11-10 | The Governing Council Of The University Of Toronto | Method of processing dried samples using digital microfluidic device |
WO2012012090A2 (en) | 2010-06-30 | 2012-01-26 | Advanced Liquid Logic, Inc. | Droplet actuator assemblies and methods of making same |
EP2711079B1 (en) | 2011-05-09 | 2018-12-19 | Advanced Liquid Logic, Inc. | Microfluidic Feedback Using Impedance Detection |
CN103597356A (en) | 2011-05-10 | 2014-02-19 | 先进流体逻辑公司 | Enzyme concentration and assays |
US8901043B2 (en) | 2011-07-06 | 2014-12-02 | Advanced Liquid Logic, Inc. | Systems for and methods of hybrid pyrosequencing |
WO2013009927A2 (en) | 2011-07-11 | 2013-01-17 | Advanced Liquid Logic, Inc. | Droplet actuators and techniques for droplet-based assays |
WO2013016413A2 (en) | 2011-07-25 | 2013-01-31 | Advanced Liquid Logic Inc | Droplet actuator apparatus and system |
WO2013078216A1 (en) | 2011-11-21 | 2013-05-30 | Advanced Liquid Logic Inc | Glucose-6-phosphate dehydrogenase assays |
CA2861959A1 (en) | 2012-01-25 | 2013-08-01 | Gencell Biosystems Limited | Biomolecule isolation |
US9223317B2 (en) | 2012-06-14 | 2015-12-29 | Advanced Liquid Logic, Inc. | Droplet actuators that include molecular barrier coatings |
EP2867645B1 (en) | 2012-06-27 | 2019-06-05 | Advanced Liquid Logic, Inc. | Techniques and droplet actuator designs for reducing bubble formation |
WO2014062551A1 (en) | 2012-10-15 | 2014-04-24 | Advanced Liquid Logic, Inc. | Digital microfluidics cartridge and system for operating a flow cell |
US9597648B2 (en) | 2012-10-17 | 2017-03-21 | The Procter & Gamble Company | Non-spherical droplet |
US20140322706A1 (en) | 2012-10-24 | 2014-10-30 | Jon Faiz Kayyem | Integrated multipelx target analysis |
JP6466336B2 (en) | 2012-10-24 | 2019-02-06 | ジェンマーク ダイアグノスティクス, インコーポレイテッド | Integrated multiple target analysis |
US9492824B2 (en) * | 2013-01-16 | 2016-11-15 | Sharp Kabushiki Kaisha | Efficient dilution method, including washing method for immunoassay |
US9453613B2 (en) | 2013-03-15 | 2016-09-27 | Genmark Diagnostics, Inc. | Apparatus, devices, and methods for manipulating deformable fluid vessels |
US9498778B2 (en) | 2014-11-11 | 2016-11-22 | Genmark Diagnostics, Inc. | Instrument for processing cartridge for performing assays in a closed sample preparation and reaction system |
USD881409S1 (en) | 2013-10-24 | 2020-04-14 | Genmark Diagnostics, Inc. | Biochip cartridge |
CN104165832B (en) * | 2014-08-15 | 2016-08-17 | 东南大学 | The wireless measurement device of a kind of three-dimensional dense gas-solid system aspherical particle concentration and method |
WO2016073159A1 (en) * | 2014-11-04 | 2016-05-12 | Applied Materials, Inc. | Sensors employing control systems determining locations of movable droplets within passageways, and related methods |
EP3218108B1 (en) | 2014-11-11 | 2020-09-02 | Genmark Diagnostics Inc. | Fluid sample processing cartridge and use thereof |
US10005080B2 (en) | 2014-11-11 | 2018-06-26 | Genmark Diagnostics, Inc. | Instrument and cartridge for performing assays in a closed sample preparation and reaction system employing electrowetting fluid manipulation |
US9598722B2 (en) | 2014-11-11 | 2017-03-21 | Genmark Diagnostics, Inc. | Cartridge for performing assays in a closed sample preparation and reaction system |
CN208562324U (en) | 2015-06-05 | 2019-03-01 | 米罗库鲁斯公司 | Digital microcurrent-controlled (DMF) device of air matrix |
EP3303547A4 (en) | 2015-06-05 | 2018-12-19 | Miroculus Inc. | Air-matrix digital microfluidics apparatuses and methods for limiting evaporation and surface fouling |
JP2020501107A (en) | 2016-08-22 | 2020-01-16 | ミロキュラス インコーポレイテッド | Feedback system for parallel droplet control in digital microfluidic devices |
EP3516401A1 (en) | 2016-09-19 | 2019-07-31 | Genmark Diagnostics Inc. | Instrument for processing cartridge for performing assays in a closed sample preparation and reaction system |
CA3049416A1 (en) | 2016-12-28 | 2018-07-05 | Miroculus Inc. | Digital microfluidic devices and methods |
WO2018187476A1 (en) | 2017-04-04 | 2018-10-11 | Miroculus Inc. | Digital microfluidic apparatuses and methods for manipulating and processing encapsulated droplets |
CN110892258A (en) | 2017-07-24 | 2020-03-17 | 米罗库鲁斯公司 | Digital microfluidic system and method with integrated plasma collection device |
EP3676009A4 (en) | 2017-09-01 | 2021-06-16 | Miroculus Inc. | Digital microfluidics devices and methods of using them |
CN112469504B (en) | 2018-05-23 | 2024-08-16 | 米罗库鲁斯公司 | Control of evaporation in digital microfluidics |
US11207688B2 (en) * | 2018-06-25 | 2021-12-28 | Sharp Life Science (Eu) Limited | Adpative droplet operations in an AM-EWOD device based on test measurement of droplet properties |
EP3953041A4 (en) | 2019-04-08 | 2023-01-25 | Miroculus Inc. | Multi-cartridge digital microfluidics apparatuses and methods of use |
WO2021016614A1 (en) | 2019-07-25 | 2021-01-28 | Miroculus Inc. | Digital microfluidics devices and methods of use thereof |
US11136543B1 (en) | 2020-02-11 | 2021-10-05 | Edward R. Flynn | Magnetic cell incubation device |
US11857961B2 (en) | 2022-01-12 | 2024-01-02 | Miroculus Inc. | Sequencing by synthesis using mechanical compression |
WO2024059707A2 (en) * | 2022-09-16 | 2024-03-21 | Siemens Healthcare Diagnostics Inc. | Improving signal to noise in immunoassays |
Family Cites Families (300)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US783807A (en) * | 1902-07-28 | 1905-02-28 | Julius Tuteur | Joist-hanger. |
US1220219A (en) * | 1915-03-27 | 1917-03-27 | Barney Goldman | Sectional skylight. |
US4001995A (en) * | 1975-09-08 | 1977-01-11 | Field Form, Inc. | Metal roofing/siding system |
US4089145A (en) * | 1976-09-01 | 1978-05-16 | Wm. Devries & Sons, Inc. | Metal roof construction |
US4139974A (en) * | 1976-09-07 | 1979-02-20 | Atlanta Metal Products, Inc. | Standing T-rib roof system |
US4075811A (en) * | 1976-11-11 | 1978-02-28 | Nordam | Building roof panel |
US4184299A (en) * | 1977-06-27 | 1980-01-22 | A & S Building Systems, Inc. | Roof construction |
US4435935A (en) * | 1980-10-08 | 1984-03-13 | Perfil En Frio, S.A. (Perfrisa) | Panel joining system |
IL61314A (en) * | 1980-10-20 | 1984-06-29 | Dan Pal Tech Plastic Ind | Light-transmitting wall panels |
US4390403A (en) | 1981-07-24 | 1983-06-28 | Batchelder J Samuel | Method and apparatus for dielectrophoretic manipulation of chemical species |
US4435937A (en) * | 1982-03-08 | 1984-03-13 | Armco Inc. | Concealed fastener support for interlocked channel section panels |
US4454232A (en) | 1982-06-07 | 1984-06-12 | Bio-Rad Laboratories, Inc. | Estriol assay |
US4570404A (en) * | 1983-03-07 | 1986-02-18 | Knudson Gary Art | Two-part hold-down apparatus with slip joint for seamed panel assemblies |
FR2543320B1 (en) | 1983-03-23 | 1986-01-31 | Thomson Csf | INDICATOR DEVICE WITH ELECTRICALLY CONTROLLED MOVEMENT OF A FLUID |
US4641475A (en) * | 1983-11-07 | 1987-02-10 | Berridge Manufacturing Co. | Moisture resistant seam assembly |
CA1206719A (en) * | 1984-05-08 | 1986-07-02 | Minialoff, Edward P. | Panel and gutter assembly |
US4863849A (en) | 1985-07-18 | 1989-09-05 | New York Medical College | Automatable process for sequencing nucleotide |
US4649684A (en) * | 1985-10-04 | 1987-03-17 | Mm Systems Corporation | Panel systems and installations |
US6013531A (en) | 1987-10-26 | 2000-01-11 | Dade International Inc. | Method to use fluorescent magnetic polymer particles as markers in an immunoassay |
US5225332A (en) | 1988-04-22 | 1993-07-06 | Massachusetts Institute Of Technology | Process for manipulation of non-aqueous surrounded microdroplets |
IL86461A (en) * | 1988-05-20 | 1990-11-05 | Dan Pal Tech Plastic Ind | Light-transmitting wall panels |
US4920725A (en) * | 1989-02-14 | 1990-05-01 | Truswal Systems Corporation | Self-gripping hanger device |
SE467309B (en) | 1990-10-22 | 1992-06-29 | Berol Nobel Ab | HYDROPHILIZED FIXED SURFACE, PROCEDURE FOR ITS PREPARATION AND AGENTS THEREOF |
US5181016A (en) | 1991-01-15 | 1993-01-19 | The United States Of America As Represented By The United States Department Of Energy | Micro-valve pump light valve display |
US5498392A (en) | 1992-05-01 | 1996-03-12 | Trustees Of The University Of Pennsylvania | Mesoscale polynucleotide amplification device and method |
US5472881A (en) | 1992-11-12 | 1995-12-05 | University Of Utah Research Foundation | Thiol labeling of DNA for attachment to gold surfaces |
US6152181A (en) | 1992-11-16 | 2000-11-28 | The United States Of America As Represented By The Secretary Of The Air Force | Microdevices based on surface tension and wettability that function as sensors, actuators, and other devices |
US20010011224A1 (en) | 1995-06-07 | 2001-08-02 | Stephen James Brown | Modular microprocessor-based health monitoring system |
GB9311241D0 (en) | 1993-06-01 | 1993-07-21 | Celsis Ltd | Reagents for use in bioluminescence |
EP0636413B1 (en) | 1993-07-28 | 2001-11-14 | PE Corporation (NY) | Nucleic acid amplification reaction apparatus and method |
US5486337A (en) | 1994-02-18 | 1996-01-23 | General Atomics | Device for electrostatic manipulation of droplets |
DE4418513A1 (en) | 1994-05-27 | 1995-11-30 | Bayer Ag | Detecting antigen using specific monoclonal antibody |
US6613560B1 (en) | 1994-10-19 | 2003-09-02 | Agilent Technologies, Inc. | PCR microreactor for amplifying DNA using microquantities of sample fluid |
JP3398749B2 (en) | 1994-11-10 | 2003-04-21 | オーキッド バイオ サイエンシズ, インコーポレイテッド | Liquid distribution system |
US6673533B1 (en) | 1995-03-10 | 2004-01-06 | Meso Scale Technologies, Llc. | Multi-array multi-specific electrochemiluminescence testing |
US6319668B1 (en) | 1995-04-25 | 2001-11-20 | Discovery Partners International | Method for tagging and screening molecules |
CA2176053C (en) | 1995-05-09 | 1999-10-05 | Yoshihiro Kinoshita | Method and apparatus for agglutination immunoassay |
US5721851A (en) | 1995-07-31 | 1998-02-24 | International Business Machines Corporation | Transient link indicators in image maps |
US6130098A (en) | 1995-09-15 | 2000-10-10 | The Regents Of The University Of Michigan | Moving microdroplets |
US5851769A (en) | 1995-09-27 | 1998-12-22 | The Regents Of The University Of California | Quantitative DNA fiber mapping |
US5945281A (en) | 1996-02-02 | 1999-08-31 | Becton, Dickinson And Company | Method and apparatus for determining an analyte from a sample fluid |
US5737892A (en) * | 1996-05-17 | 1998-04-14 | Crown Partnership | Channel-mounted interlocking panel roofing structure |
GB9620209D0 (en) | 1996-09-27 | 1996-11-13 | Cemu Bioteknik Ab | Method of sequencing DNA |
AU746549B2 (en) | 1996-11-20 | 2002-05-02 | Becton Dickinson & Company | Microfabricated isothermal nucleic acid amplification devices and methods |
GB9626815D0 (en) | 1996-12-23 | 1997-02-12 | Cemu Bioteknik Ab | Method of sequencing DNA |
US6143496A (en) | 1997-04-17 | 2000-11-07 | Cytonix Corporation | Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly |
DE19717085C2 (en) | 1997-04-23 | 1999-06-17 | Bruker Daltonik Gmbh | Processes and devices for extremely fast DNA multiplication using polymerase chain reactions (PCR) |
US6106685A (en) | 1997-05-13 | 2000-08-22 | Sarnoff Corporation | Electrode combinations for pumping fluids |
US5980719A (en) | 1997-05-13 | 1999-11-09 | Sarnoff Corporation | Electrohydrodynamic receptor |
US5998224A (en) | 1997-05-16 | 1999-12-07 | Abbott Laboratories | Magnetically assisted binding assays utilizing a magnetically responsive reagent |
US6375871B1 (en) | 1998-06-18 | 2002-04-23 | 3M Innovative Properties Company | Methods of manufacturing microfluidic articles |
US20020001544A1 (en) | 1997-08-28 | 2002-01-03 | Robert Hess | System and method for high throughput processing of droplets |
WO1999015876A1 (en) | 1997-09-19 | 1999-04-01 | Aclara Biosciences, Inc. | Apparatus and method for transferring liquids |
US7214298B2 (en) | 1997-09-23 | 2007-05-08 | California Institute Of Technology | Microfabricated cell sorter |
JP2000516345A (en) | 1997-11-18 | 2000-12-05 | バイオ―ラッド ラボラトリーズ インコーポレイテッド | Multiple flow immunoassay using magnetic particles as solid phase |
DE19822123C2 (en) | 1997-11-21 | 2003-02-06 | Meinhard Knoll | Method and device for the detection of analytes |
US6063339A (en) | 1998-01-09 | 2000-05-16 | Cartesian Technologies, Inc. | Method and apparatus for high-speed dot array dispensing |
DE69926157T2 (en) * | 1998-01-29 | 2006-05-24 | Politec Polimeri Tecnici S.A. | Plate connecting devices |
EP1054735B1 (en) | 1998-02-11 | 2003-05-28 | Institut Für Physikalische Hochtechnologie E.V. | Miniaturized temperature-zone flow reactor |
EP0949390B1 (en) * | 1998-03-12 | 2005-07-20 | Politec Polimeri Tecnici S.A. | Improvements relating to panel coupling assemblies |
FI980874A (en) | 1998-04-20 | 1999-10-21 | Wallac Oy | Method and apparatus for conducting chemical analysis on small amounts of liquid |
US6226082B1 (en) | 1998-06-25 | 2001-05-01 | Amira Medical | Method and apparatus for the quantitative analysis of a liquid sample with surface enhanced spectroscopy |
US6591852B1 (en) | 1998-10-13 | 2003-07-15 | Biomicro Systems, Inc. | Fluid circuit components based upon passive fluid dynamics |
US20030012699A1 (en) | 1998-11-18 | 2003-01-16 | Thomas Moore | Simultaneous handling of magnetic beads in a two-dimensional arrangement |
GB9901475D0 (en) | 1999-01-22 | 1999-03-17 | Pyrosequencing Ab | A method of DNA sequencing |
US6565727B1 (en) | 1999-01-25 | 2003-05-20 | Nanolytics, Inc. | Actuators for microfluidics without moving parts |
US6294063B1 (en) | 1999-02-12 | 2001-09-25 | Board Of Regents, The University Of Texas System | Method and apparatus for programmable fluidic processing |
ATE508200T1 (en) | 1999-02-23 | 2011-05-15 | Caliper Life Sciences Inc | SEQUENCING THROUGH INCORPORATION |
US6225061B1 (en) | 1999-03-10 | 2001-05-01 | Sequenom, Inc. | Systems and methods for performing reactions in an unsealed environment |
DE60036746T2 (en) | 1999-03-25 | 2008-07-24 | Tosoh Corp., Shinnanyo | analyzer |
IT1309430B1 (en) | 1999-05-18 | 2002-01-23 | Guerrieri Roberto | METHOD AND APPARATUS FOR HANDLING PARTICLES BY MEANS OF ELECTROPHORESIS |
US6942776B2 (en) | 1999-05-18 | 2005-09-13 | Silicon Biosystems S.R.L. | Method and apparatus for the manipulation of particles by means of dielectrophoresis |
FR2794039B1 (en) | 1999-05-27 | 2002-05-03 | Osmooze Sa | DEVICE FOR FORMING, MOVING AND DIFFUSING SMALL CALIBRATED QUANTITIES OF LIQUIDS |
US6664104B2 (en) | 1999-06-25 | 2003-12-16 | Cepheid | Device incorporating a microfluidic chip for separating analyte from a sample |
US6977145B2 (en) | 1999-07-28 | 2005-12-20 | Serono Genetics Institute S.A. | Method for carrying out a biochemical protocol in continuous flow in a microreactor |
DE19938002A1 (en) | 1999-08-11 | 2001-02-15 | Studiengesellschaft Kohle Mbh | Coating with cross-linked hydrophilic polymers |
US6495104B1 (en) | 1999-08-19 | 2002-12-17 | Caliper Technologies Corp. | Indicator components for microfluidic systems |
US20030027204A1 (en) | 1999-09-03 | 2003-02-06 | Yokogawa Electric Corporation, A Japan Corporation | Method and apparatus for producing biochips |
US20040209376A1 (en) | 1999-10-01 | 2004-10-21 | Surromed, Inc. | Assemblies of differentiable segmented particles |
ATE328670T1 (en) | 1999-11-11 | 2006-06-15 | Trinity College Dublin | DEVICE AND METHOD FOR ADMINISTRATION OF DROPS |
US6432290B1 (en) | 1999-11-26 | 2002-08-13 | The Governors Of The University Of Alberta | Apparatus and method for trapping bead based reagents within microfluidic analysis systems |
SE9904802D0 (en) | 1999-12-23 | 1999-12-23 | Amersham Pharm Biotech Ab | Microfluidic surfaces |
EP1272768A4 (en) | 2000-02-23 | 2005-09-07 | Zyomyx Inc | Microfluidic devices and methods |
IT1317120B1 (en) * | 2000-03-07 | 2003-05-27 | Politec Polimeri Tecnici Sa | ASSEMBLY OF PANELS AND JOINT ELEMENTS |
US6924792B1 (en) | 2000-03-10 | 2005-08-02 | Richard V. Jessop | Electrowetting and electrostatic screen display systems, colour displays and transmission means |
JP3442338B2 (en) | 2000-03-17 | 2003-09-02 | 株式会社日立製作所 | DNA analyzer, DNA base sequencer, DNA base sequence determination method, and reaction module |
US6442413B1 (en) | 2000-05-15 | 2002-08-27 | James H. Silver | Implantable sensor |
AU2001280796A1 (en) | 2000-07-25 | 2002-02-05 | The Regents Of The University Of California | Electrowetting-driven micropumping |
CA2314398A1 (en) | 2000-08-10 | 2002-02-10 | Edward Shipwash | Microarrays and microsystems for amino acid analysis and protein sequencing |
US6773566B2 (en) | 2000-08-31 | 2004-08-10 | Nanolytics, Inc. | Electrostatic actuators for microfluidics and methods for using same |
GB0021977D0 (en) | 2000-09-07 | 2000-10-25 | Pyrosequencing Ab | Method of sequencing DNA |
EP2299256A3 (en) | 2000-09-15 | 2012-10-10 | California Institute Of Technology | Microfabricated crossflow devices and methods |
US20020142483A1 (en) | 2000-10-30 | 2002-10-03 | Sequenom, Inc. | Method and apparatus for delivery of submicroliter volumes onto a substrate |
WO2002039462A2 (en) | 2000-11-09 | 2002-05-16 | Koninklijke Philips Electronics N.V. | Multi-fluid elements device with controllable fluid level by means of matrix addressing |
US6453928B1 (en) | 2001-01-08 | 2002-09-24 | Nanolab Ltd. | Apparatus, and method for propelling fluids |
US20020102595A1 (en) | 2001-01-29 | 2002-08-01 | Davis Lloyd Mervyn | Methods for detection of incorporation of a nucleotide onto a nucleic acid primer |
KR100398309B1 (en) | 2001-02-20 | 2003-09-19 | 한국과학기술원 | Micropump actuated by the movement of liquid drop induced by continuous electrowetting |
US7078168B2 (en) | 2001-02-27 | 2006-07-18 | Biotage Ab | Method for determining allele frequencies |
WO2002068821A2 (en) | 2001-02-28 | 2002-09-06 | Lightwave Microsystems Corporation | Microfluidic control using dieletric pumping |
US7016560B2 (en) | 2001-02-28 | 2006-03-21 | Lightwave Microsystems Corporation | Microfluidic control for waveguide optical switches, variable attenuators, and other optical devices |
US7010391B2 (en) | 2001-03-28 | 2006-03-07 | Handylab, Inc. | Methods and systems for control of microfluidic devices |
EP1384022A4 (en) | 2001-04-06 | 2004-08-04 | California Inst Of Techn | Nucleic acid amplification utilizing microfluidic devices |
US6665127B2 (en) | 2002-04-30 | 2003-12-16 | Lucent Technologies Inc. | Method and apparatus for aligning a photo-tunable microlens |
US6538823B2 (en) | 2001-06-19 | 2003-03-25 | Lucent Technologies Inc. | Tunable liquid microlens |
US6965480B2 (en) | 2001-06-19 | 2005-11-15 | Lucent Technologies Inc. | Method and apparatus for calibrating a tunable microlens |
US7211442B2 (en) | 2001-06-20 | 2007-05-01 | Cytonome, Inc. | Microfluidic system including a virtual wall fluid interface port for interfacing fluids with the microfluidic system |
US7179423B2 (en) | 2001-06-20 | 2007-02-20 | Cytonome, Inc. | Microfluidic system including a virtual wall fluid interface port for interfacing fluids with the microfluidic system |
US6844028B2 (en) | 2001-06-26 | 2005-01-18 | Accelr8 Technology Corporation | Functional surface coating |
US6734436B2 (en) | 2001-08-07 | 2004-05-11 | Sri International | Optical microfluidic devices and methods |
US6995024B2 (en) | 2001-08-27 | 2006-02-07 | Sri International | Method and apparatus for electrostatic dispensing of microdroplets |
US6545815B2 (en) | 2001-09-13 | 2003-04-08 | Lucent Technologies Inc. | Tunable liquid microlens with lubrication assisted electrowetting |
US7094379B2 (en) | 2001-10-24 | 2006-08-22 | Commissariat A L'energie Atomique | Device for parallel and synchronous injection for sequential injection of different reagents |
WO2003045556A2 (en) | 2001-11-26 | 2003-06-05 | Keck Graduate Institute | Method, apparatus and article for microfluidic control via electrowetting, for chemical, biochemical and biological assays and the like |
US20040231987A1 (en) | 2001-11-26 | 2004-11-25 | Keck Graduate Institute | Method, apparatus and article for microfluidic control via electrowetting, for chemical, biochemical and biological assays and the like |
GB0129068D0 (en) | 2001-12-05 | 2002-01-23 | Koninl Philips Electronics Nv | Display device |
JP2005511066A (en) | 2001-12-07 | 2005-04-28 | ダイアックス、コープ | Method and apparatus for cleaning magnetically responsive particles |
US20030119057A1 (en) | 2001-12-20 | 2003-06-26 | Board Of Regents | Forming and modifying dielectrically-engineered microparticles |
DE10164357B4 (en) | 2001-12-28 | 2005-11-10 | Advalytix Ag | titration |
CA2472649A1 (en) | 2002-01-08 | 2003-07-17 | Japan Science And Technology Agency | Pcr and hybridization methods utilizing electrostatic transportation and devices therefor |
WO2003069380A1 (en) | 2002-02-14 | 2003-08-21 | Koninklijke Philips Electronics N.V. | Variable focus lens |
AU2003215340A1 (en) | 2002-02-22 | 2003-09-09 | Nanostream, Inc. | Ratiometric dilution devices and methods |
US6936196B2 (en) | 2002-03-12 | 2005-08-30 | Lucent Technologies Inc. | Solidifiable tunable liquid microlens |
US20050148042A1 (en) | 2002-03-29 | 2005-07-07 | Glenn Prestwich | Hybrid phosphoinositide phospholipids: compositions and uses |
US7147763B2 (en) | 2002-04-01 | 2006-12-12 | Palo Alto Research Center Incorporated | Apparatus and method for using electrostatic force to cause fluid movement |
US6845592B2 (en) * | 2002-04-05 | 2005-01-25 | Extech Exterior Technologies, Inc. | Panel clip assembly for use with skylight or roof panels |
US6958132B2 (en) | 2002-05-31 | 2005-10-25 | The Regents Of The University Of California | Systems and methods for optical actuation of microfluidics based on opto-electrowetting |
FR2841063B1 (en) | 2002-06-18 | 2004-09-17 | Commissariat Energie Atomique | DEVICE FOR DISPLACING SMALL VOLUMES OF LIQUID ALONG A MICRO-CATENARY BY ELECTROSTATIC FORCES |
JP2006507921A (en) | 2002-06-28 | 2006-03-09 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | Method and apparatus for fluid dispersion |
FR2843048B1 (en) | 2002-08-01 | 2004-09-24 | Commissariat Energie Atomique | DEVICE FOR INJECTING AND MIXING LIQUID MICRO-DROPS. |
US6988344B1 (en) * | 2002-08-09 | 2006-01-24 | Concord Industrial Corp. | Modular wall structural elements, and methods of using same |
US20040091392A1 (en) | 2002-08-09 | 2004-05-13 | Mcbride Sterling Eduard | Method and apparatus for employing a tunable microfluidic device for optical switching, filtering and assaying of biological samples |
US6829415B2 (en) | 2002-08-30 | 2004-12-07 | Lucent Technologies Inc. | Optical waveguide devices with electro-wetting actuation |
JP2006500618A (en) | 2002-09-19 | 2006-01-05 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Electrowetting optical switch |
US6911132B2 (en) | 2002-09-24 | 2005-06-28 | Duke University | Apparatus for manipulating droplets by electrowetting-based techniques |
US6989234B2 (en) | 2002-09-24 | 2006-01-24 | Duke University | Method and apparatus for non-contact electrostatic actuation of droplets |
US7329545B2 (en) | 2002-09-24 | 2008-02-12 | Duke University | Methods for sampling a liquid flow |
US7217542B2 (en) | 2002-10-31 | 2007-05-15 | Hewlett-Packard Development Company, L.P. | Microfluidic system for analyzing nucleic acids |
FR2846957B1 (en) | 2002-11-13 | 2005-09-30 | Commissariat Energie Atomique | MICRO-SYSTEM FILLING MICROBALLS AND PROCESS FOR OBTAINING THE SAME |
US7547380B2 (en) | 2003-01-13 | 2009-06-16 | North Carolina State University | Droplet transportation devices and methods having a fluid surface |
GB0304033D0 (en) | 2003-02-21 | 2003-03-26 | Imp College Innovations Ltd | Apparatus |
US7041481B2 (en) | 2003-03-14 | 2006-05-09 | The Regents Of The University Of California | Chemical amplification based on fluid partitioning |
EP1623264B1 (en) | 2003-05-06 | 2015-11-04 | Koninklijke Philips N.V. | Switchable optical element using surfactants |
JP4404672B2 (en) | 2003-05-28 | 2010-01-27 | セイコーエプソン株式会社 | Droplet ejection head, droplet ejection head manufacturing method, microarray manufacturing apparatus, and microarray manufacturing method |
US20050014255A1 (en) | 2003-05-29 | 2005-01-20 | Board Of Regents, The University Of Texas System | Stem cells for clinical and commercial uses |
US7926236B2 (en) * | 2003-06-27 | 2011-04-19 | Konvin Associates Limited Partnership | Light transmission panels, retaining clip and a combination thereof |
TWI230760B (en) | 2003-07-29 | 2005-04-11 | Univ Tsinghua | Electrowetting electrode design with electromagnetic field for actuation of the magnetic-beads biochemical detection system |
US7767435B2 (en) | 2003-08-25 | 2010-08-03 | University Of Washington | Method and device for biochemical detection and analysis of subcellular compartments from a single cell |
CA2479452C (en) | 2003-08-30 | 2008-11-04 | F.Hoffmann-La Roche Ag | Method and device for determining analytes in a liquid |
US7488451B2 (en) | 2003-09-15 | 2009-02-10 | Millipore Corporation | Systems for particle manipulation |
AU2004283721B2 (en) | 2003-10-24 | 2009-08-13 | Adhesives Research, Inc. | Rapidly disintegrating film |
RU2363951C2 (en) | 2003-10-29 | 2009-08-10 | Мек Динамикс Корп. | Micromechanical ways and devices for carrying out of analyses |
US7313893B2 (en) * | 2003-11-13 | 2008-01-01 | Extech/Exterior Technologies, Inc. | Panel clip assembly for use with roof or wall panels |
CN100478075C (en) | 2003-11-17 | 2009-04-15 | 皇家飞利浦电子股份有限公司 | System for manipulation of a body of fluid |
KR100647282B1 (en) | 2003-12-24 | 2006-11-17 | 삼성전자주식회사 | Spoting device for manufacturing DNA microarray and spoting method using the same |
US7362432B2 (en) | 2004-01-14 | 2008-04-22 | Luminex Corp. | Method and systems for dynamic range expansion |
WO2005069015A1 (en) | 2004-01-15 | 2005-07-28 | Japan Science And Technology Agency | Chemical analysis apparatus and method of chemical analysis |
ES2432040T3 (en) | 2004-01-28 | 2013-11-29 | 454 Life Sciences Corporation | Nucleic acid amplification with continuous flow emulsion |
FR2866493B1 (en) | 2004-02-16 | 2010-08-20 | Commissariat Energie Atomique | DEVICE FOR CONTROLLING THE DISPLACEMENT OF A DROP BETWEEN TWO OR MORE SOLID SUBSTRATES |
KR100552706B1 (en) | 2004-03-12 | 2006-02-20 | 삼성전자주식회사 | Method and apparatus for nucleic acid amplification |
ES2382475T3 (en) | 2004-03-23 | 2012-06-08 | Toray Industries, Inc. | Solution stirring procedure |
US7048889B2 (en) | 2004-03-23 | 2006-05-23 | Lucent Technologies Inc. | Dynamically controllable biological/chemical detectors having nanostructured surfaces |
KR100583231B1 (en) | 2004-04-13 | 2006-05-26 | 한국과학기술연구원 | Apparatus of Isolating Cell Using Droplet Type Cell Suspension |
WO2006085905A1 (en) | 2004-05-28 | 2006-08-17 | Board Of Regents, The University Of Texas System | Programmable fluidic processors |
US7799553B2 (en) | 2004-06-01 | 2010-09-21 | The Regents Of The University Of California | Microfabricated integrated DNA analysis system |
FR2871076A1 (en) | 2004-06-04 | 2005-12-09 | Univ Lille Sciences Tech | DEVICE FOR LASER RADIATION DESORPTION INCORPORATING HANDLING OF THE LIQUID SAMPLE IN THE FORM OF INDIVIDUAL DROPS ENABLING THEIR CHEMICAL AND BIOCHEMICAL TREATMENT |
FR2872438B1 (en) | 2004-07-01 | 2006-09-15 | Commissariat Energie Atomique | DEVICE FOR DISPLACING AND PROCESSING LIQUID VOLUMES |
US7693666B2 (en) | 2004-07-07 | 2010-04-06 | Rensselaer Polytechnic Institute | Method, system, and program product for controlling chemical reactions in a digital microfluidic system |
FR2872715B1 (en) | 2004-07-08 | 2006-11-17 | Commissariat Energie Atomique | MICROREACTOR DROP |
FR2872809B1 (en) | 2004-07-09 | 2006-09-15 | Commissariat Energie Atomique | METHOD OF ADDRESSING ELECTRODES |
WO2006025982A2 (en) | 2004-07-28 | 2006-03-09 | University Of Rochester | Rapid flow fractionation of particles combining liquid and particulate dielectrophoresis |
JP2006058031A (en) | 2004-08-17 | 2006-03-02 | Hitachi High-Technologies Corp | Chemical analyzer |
DE602005024418D1 (en) | 2004-08-26 | 2010-12-09 | Life Technologies Corp | ELECTROCONDUCTING DISPENSERS AND METHODS THEREFOR |
JP4047314B2 (en) | 2004-09-07 | 2008-02-13 | 株式会社東芝 | Fine channel structure |
ES2784184T3 (en) | 2004-09-09 | 2020-09-23 | Inst Curie | Microfluidic device that uses a collinear electric field |
JP4185904B2 (en) | 2004-10-27 | 2008-11-26 | 株式会社日立ハイテクノロジーズ | Liquid transfer substrate, analysis system, and analysis method |
US20060132927A1 (en) | 2004-11-30 | 2006-06-22 | Yoon Frank C | Electrowetting chromatophore |
FR2879946B1 (en) | 2004-12-23 | 2007-02-09 | Commissariat Energie Atomique | DISPENSER DEVICE FOR DROPS |
US7458661B2 (en) | 2005-01-25 | 2008-12-02 | The Regents Of The University Of California | Method and apparatus for promoting the complete transfer of liquid drops from a nozzle |
KR101198038B1 (en) | 2005-01-28 | 2012-11-06 | 듀크 유니버서티 | Apparatuses and methods for manipulating droplets on a printed circuit board |
US7454988B2 (en) | 2005-02-10 | 2008-11-25 | Applera Corporation | Method for fluid sampling using electrically controlled droplets |
US20060210443A1 (en) | 2005-03-14 | 2006-09-21 | Stearns Richard G | Avoidance of bouncing and splashing in droplet-based fluid transport |
JP4559274B2 (en) | 2005-03-30 | 2010-10-06 | シャープ株式会社 | Image display device |
FR2884437B1 (en) | 2005-04-19 | 2007-07-20 | Commissariat Energie Atomique | MICROFLUIDIC DEVICE AND METHOD FOR THE TRANSFER OF MATERIAL BETWEEN TWO IMMISCIBLE PHASES. |
CA2606750C (en) | 2005-05-11 | 2015-11-24 | Nanolytics, Inc. | Method and device for conducting biochemical or chemical reactions at multiple temperatures |
JP4547301B2 (en) | 2005-05-13 | 2010-09-22 | 株式会社日立ハイテクノロジーズ | Liquid transport device and analysis system |
JP2006317364A (en) | 2005-05-16 | 2006-11-24 | Hitachi High-Technologies Corp | Dispenser |
US8481125B2 (en) | 2005-05-21 | 2013-07-09 | Advanced Liquid Logic Inc. | Mitigation of biomolecular adsorption with hydrophilic polymer additives |
JP4500733B2 (en) | 2005-05-30 | 2010-07-14 | 株式会社日立ハイテクノロジーズ | Chemical analyzer |
JP2006329904A (en) | 2005-05-30 | 2006-12-07 | Hitachi High-Technologies Corp | Liquid transfer device and analysis system |
JP4969060B2 (en) | 2005-06-08 | 2012-07-04 | 株式会社日立ハイテクノロジーズ | Automatic analyzer |
WO2006138543A1 (en) | 2005-06-16 | 2006-12-28 | Core-Microsolutions, Inc. | Biosensor detection by means of droplet driving, agitation, and evaporation |
FR2887305B1 (en) | 2005-06-17 | 2011-05-27 | Commissariat Energie Atomique | DEVICE FOR PUMPING BY ELECTROWETTING AND APPLICATION TO MEASUREMENTS OF ELECTRIC ACTIVITY |
EP1899048B1 (en) | 2005-07-01 | 2008-12-17 | Commissariat A L'energie Atomique | Low wetting hysteresis hydrophobic surface coating, method for depositing same, microcomponent and use |
FR2888912B1 (en) | 2005-07-25 | 2007-08-24 | Commissariat Energie Atomique | METHOD FOR CONTROLLING COMMUNICATION BETWEEN TWO ZONES BY ELECTROWRINKING, DEVICE COMPRISING ISOLABLE ZONES AND OTHERS AND METHOD FOR PRODUCING SUCH DEVICE |
US20070023292A1 (en) | 2005-07-26 | 2007-02-01 | The Regents Of The University Of California | Small object moving on printed circuit board |
WO2007024914A2 (en) | 2005-08-22 | 2007-03-01 | Applera Corporation | Device and method for microfluidic control of a first fluid in contact with a second fluid, wherein the first and second fluids are immiscible |
US7556776B2 (en) | 2005-09-08 | 2009-07-07 | President And Fellows Of Harvard College | Microfluidic manipulation of fluids and reactions |
CN102622746B (en) | 2005-09-21 | 2016-05-25 | 卢米尼克斯股份有限公司 | The method and system of view data processing |
FR2890875B1 (en) | 2005-09-22 | 2008-02-22 | Commissariat Energie Atomique | MANUFACTURING A DIPHASIC SYSTEM LIQUID / LIQUID OR GAS IN MICRO-FLUID |
US7344679B2 (en) | 2005-10-14 | 2008-03-18 | International Business Machines Corporation | Method and apparatus for point of care osmolarity testing |
WO2007048111A2 (en) | 2005-10-22 | 2007-04-26 | Core-Microsolutions, Inc. | Droplet extraction from a liquid column for on-chip microfluidics |
WO2007076023A2 (en) | 2005-12-21 | 2007-07-05 | Meso Scale Technologies, Llc | Assay modules having assay reagents and methods of making and using same |
WO2007081386A2 (en) | 2006-01-11 | 2007-07-19 | Raindance Technologies, Inc. | Microfluidic devices and methods of use |
EP1989529A4 (en) | 2006-02-13 | 2010-09-01 | Agency Science Tech & Res | Method of processing a biological and/or chemical sample |
WO2007103859A2 (en) | 2006-03-03 | 2007-09-13 | Luminex Corporation | Methods, products, and kits for identifying an analyte in a sample |
US20070207272A1 (en) | 2006-03-03 | 2007-09-06 | Puri Ishwar K | Method and apparatus for magnetic mixing in micron size droplets |
US8613889B2 (en) | 2006-04-13 | 2013-12-24 | Advanced Liquid Logic, Inc. | Droplet-based washing |
US8492168B2 (en) | 2006-04-18 | 2013-07-23 | Advanced Liquid Logic Inc. | Droplet-based affinity assays |
KR100723425B1 (en) | 2006-04-13 | 2007-05-30 | 삼성전자주식회사 | Device and method for printing bio-drop on a substrate |
US8637317B2 (en) | 2006-04-18 | 2014-01-28 | Advanced Liquid Logic, Inc. | Method of washing beads |
WO2010006166A2 (en) | 2008-07-09 | 2010-01-14 | Advanced Liquid Logic, Inc. | Bead manipulation techniques |
US8389297B2 (en) | 2006-04-18 | 2013-03-05 | Duke University | Droplet-based affinity assay device and system |
CA2680061C (en) | 2006-04-18 | 2015-10-13 | Duke University | Droplet-based biochemistry |
WO2010042637A2 (en) | 2008-10-07 | 2010-04-15 | Advanced Liquid Logic, Inc. | Bead incubation and washing on a droplet actuator |
US8927296B2 (en) | 2006-04-18 | 2015-01-06 | Advanced Liquid Logic, Inc. | Method of reducing liquid volume surrounding beads |
US7816121B2 (en) | 2006-04-18 | 2010-10-19 | Advanced Liquid Logic, Inc. | Droplet actuation system and method |
US8685754B2 (en) | 2006-04-18 | 2014-04-01 | Advanced Liquid Logic, Inc. | Droplet actuator devices and methods for immunoassays and washing |
US8658111B2 (en) | 2006-04-18 | 2014-02-25 | Advanced Liquid Logic, Inc. | Droplet actuators, modified fluids and methods |
US8637324B2 (en) | 2006-04-18 | 2014-01-28 | Advanced Liquid Logic, Inc. | Bead incubation and washing on a droplet actuator |
US7901947B2 (en) | 2006-04-18 | 2011-03-08 | Advanced Liquid Logic, Inc. | Droplet-based particle sorting |
US8809068B2 (en) | 2006-04-18 | 2014-08-19 | Advanced Liquid Logic, Inc. | Manipulation of beads in droplets and methods for manipulating droplets |
US7763471B2 (en) | 2006-04-18 | 2010-07-27 | Advanced Liquid Logic, Inc. | Method of electrowetting droplet operations for protein crystallization |
US7815871B2 (en) | 2006-04-18 | 2010-10-19 | Advanced Liquid Logic, Inc. | Droplet microactuator system |
US8980198B2 (en) | 2006-04-18 | 2015-03-17 | Advanced Liquid Logic, Inc. | Filler fluids for droplet operations |
WO2007123908A2 (en) | 2006-04-18 | 2007-11-01 | Advanced Liquid Logic, Inc. | Droplet-based multiwell operations |
US7439014B2 (en) | 2006-04-18 | 2008-10-21 | Advanced Liquid Logic, Inc. | Droplet-based surface modification and washing |
WO2010027894A2 (en) | 2008-08-27 | 2010-03-11 | Advanced Liquid Logic, Inc. | Droplet actuators, modified fluids and methods |
US8470606B2 (en) | 2006-04-18 | 2013-06-25 | Duke University | Manipulation of beads in droplets and methods for splitting droplets |
US8716015B2 (en) | 2006-04-18 | 2014-05-06 | Advanced Liquid Logic, Inc. | Manipulation of cells on a droplet actuator |
US7822510B2 (en) | 2006-05-09 | 2010-10-26 | Advanced Liquid Logic, Inc. | Systems, methods, and products for graphically illustrating and controlling a droplet actuator |
US9675972B2 (en) | 2006-05-09 | 2017-06-13 | Advanced Liquid Logic, Inc. | Method of concentrating beads in a droplet |
US8041463B2 (en) | 2006-05-09 | 2011-10-18 | Advanced Liquid Logic, Inc. | Modular droplet actuator drive |
CA2680062C (en) | 2006-05-09 | 2015-10-20 | Duke University | Droplet manipulation systems |
WO2009026339A2 (en) | 2007-08-20 | 2009-02-26 | Advanced Liquid Logic, Inc. | Modular droplet actuator drive |
US7939021B2 (en) | 2007-05-09 | 2011-05-10 | Advanced Liquid Logic, Inc. | Droplet actuator analyzer with cartridge |
EP2530167A1 (en) | 2006-05-11 | 2012-12-05 | Raindance Technologies, Inc. | Microfluidic Devices |
WO2007146025A2 (en) | 2006-06-06 | 2007-12-21 | University Of Virginia Patent Foundation | Capillary force actuator device and related method of applications |
US7629124B2 (en) | 2006-06-30 | 2009-12-08 | Canon U.S. Life Sciences, Inc. | Real-time PCR in micro-channels |
CN101490562B (en) | 2006-07-10 | 2012-12-19 | 株式会社日立高新技术 | Liquid transfer device |
EP1905513A1 (en) | 2006-09-13 | 2008-04-02 | Institut Curie | Methods and devices for sampling fluids |
JP4901410B2 (en) | 2006-10-10 | 2012-03-21 | シャープ株式会社 | Backlight device and video display device |
US7788438B2 (en) * | 2006-10-13 | 2010-08-31 | Macronix International Co., Ltd. | Multi-input/output serial peripheral interface and method for data transmission |
US9266076B2 (en) | 2006-11-02 | 2016-02-23 | The Regents Of The University Of California | Method and apparatus for real-time feedback control of electrical manipulation of droplets on chip |
FR2909293B1 (en) | 2006-12-05 | 2011-04-22 | Commissariat Energie Atomique | MICRO-DEVICE FOR PROCESSING LIQUID SAMPLES |
CN102851369B (en) | 2006-12-13 | 2015-01-21 | 卢米耐克斯公司 | Systems and methods for multiplex analysis of PCR in real time |
US8338166B2 (en) | 2007-01-04 | 2012-12-25 | Lawrence Livermore National Security, Llc | Sorting, amplification, detection, and identification of nucleic acid subsequences in a complex mixture |
US8685344B2 (en) | 2007-01-22 | 2014-04-01 | Advanced Liquid Logic, Inc. | Surface assisted fluid loading and droplet dispensing |
ES2423930T3 (en) | 2007-02-09 | 2013-09-25 | Advanced Liquid Logic, Inc. | Droplet actuator devices and methods using magnetic beads |
EP2109774B1 (en) | 2007-02-15 | 2018-07-04 | Advanced Liquid Logic, Inc. | Capacitance detection in a droplet actuator |
US20100025250A1 (en) | 2007-03-01 | 2010-02-04 | Advanced Liquid Logic, Inc. | Droplet Actuator Structures |
CN101663403B (en) | 2007-03-05 | 2013-04-24 | 先进流体逻辑公司 | Hydrogen peroxide droplet-based assays |
US8208146B2 (en) | 2007-03-13 | 2012-06-26 | Advanced Liquid Logic, Inc. | Droplet actuator devices, configurations, and methods for improving absorbance detection |
US8093062B2 (en) | 2007-03-22 | 2012-01-10 | Theodore Winger | Enzymatic assays using umbelliferone substrates with cyclodextrins in droplets in oil |
WO2008116209A1 (en) | 2007-03-22 | 2008-09-25 | Advanced Liquid Logic, Inc. | Enzymatic assays for a droplet actuator |
US20100048410A1 (en) | 2007-03-22 | 2010-02-25 | Advanced Liquid Logic, Inc. | Bead Sorting on a Droplet Actuator |
US8202686B2 (en) | 2007-03-22 | 2012-06-19 | Advanced Liquid Logic, Inc. | Enzyme assays for a droplet actuator |
US8317990B2 (en) | 2007-03-23 | 2012-11-27 | Advanced Liquid Logic Inc. | Droplet actuator loading and target concentration |
WO2010009463A2 (en) | 2008-07-18 | 2010-01-21 | Advanced Liquid Logic, Inc. | Droplet operations device |
EP2132296A4 (en) | 2007-04-10 | 2015-04-08 | Advanced Liquid Logic Inc | Droplet dispensing device and methods |
WO2009011952A1 (en) | 2007-04-23 | 2009-01-22 | Advanced Liquid Logic, Inc. | Device and method for sample collection and concentration |
WO2008134153A1 (en) | 2007-04-23 | 2008-11-06 | Advanced Liquid Logic, Inc. | Bead-based multiplexed analytical methods and instrumentation |
WO2008131420A2 (en) | 2007-04-23 | 2008-10-30 | Advanced Liquid Logic, Inc. | Sample collector and processor |
US20080283414A1 (en) | 2007-05-17 | 2008-11-20 | Monroe Charles W | Electrowetting devices |
WO2009002920A1 (en) | 2007-06-22 | 2008-12-31 | Advanced Liquid Logic, Inc. | Droplet-based nucleic acid amplification in a temperature gradient |
US8926811B2 (en) | 2007-06-27 | 2015-01-06 | Digital Biosystems | Digital microfluidics based apparatus for heat-exchanging chemical processes |
US20100120130A1 (en) | 2007-08-08 | 2010-05-13 | Advanced Liquid Logic, Inc. | Droplet Actuator with Droplet Retention Structures |
US20110303542A1 (en) | 2007-08-08 | 2011-12-15 | Advanced Liquid Logic, Inc. | Use of Additives for Enhancing Droplet Operations |
WO2009021233A2 (en) | 2007-08-09 | 2009-02-12 | Advanced Liquid Logic, Inc. | Pcb droplet actuator fabrication |
BRPI0815698A2 (en) | 2007-08-24 | 2017-06-13 | Advanced Liquid Logic Inc | bead manipulation in a droplet actuator. |
US8702938B2 (en) | 2007-09-04 | 2014-04-22 | Advanced Liquid Logic, Inc. | Droplet actuator with improved top substrate |
WO2009052095A1 (en) | 2007-10-17 | 2009-04-23 | Advanced Liquid Logic, Inc. | Reagent storage and reconstitution for a droplet actuator |
EP2212683A4 (en) | 2007-10-17 | 2011-08-31 | Advanced Liquid Logic Inc | Manipulation of beads in droplets |
US8454905B2 (en) | 2007-10-17 | 2013-06-04 | Advanced Liquid Logic Inc. | Droplet actuator structures |
US20100236928A1 (en) | 2007-10-17 | 2010-09-23 | Advanced Liquid Logic, Inc. | Multiplexed Detection Schemes for a Droplet Actuator |
WO2009052321A2 (en) | 2007-10-18 | 2009-04-23 | Advanced Liquid Logic, Inc. | Droplet actuators, systems and methods |
US7621059B2 (en) | 2007-10-18 | 2009-11-24 | Oceaneering International, Inc. | Underwater sediment evacuation system |
EP2232535A4 (en) | 2007-12-10 | 2016-04-13 | Advanced Liquid Logic Inc | Droplet actuator configurations and methods |
AU2008345138B2 (en) | 2007-12-23 | 2014-05-29 | Advanced Liquid Logic, Inc. | Droplet actuator configurations and methods of conducting droplet operations |
WO2009135205A2 (en) | 2008-05-02 | 2009-11-05 | Advanced Liquid Logic, Inc. | Droplet actuator techniques using coagulatable samples |
WO2009137415A2 (en) | 2008-05-03 | 2009-11-12 | Advanced Liquid Logic, Inc. | Reagent and sample preparation, loading, and storage |
US20110097763A1 (en) | 2008-05-13 | 2011-04-28 | Advanced Liquid Logic, Inc. | Thermal Cycling Method |
DK2279405T3 (en) | 2008-05-13 | 2014-01-13 | Advanced Liquid Logic Inc | Drip actuator devices, systems and methods |
US8093064B2 (en) | 2008-05-15 | 2012-01-10 | The Regents Of The University Of California | Method for using magnetic particles in droplet microfluidics |
FR2933713B1 (en) | 2008-07-11 | 2011-03-25 | Commissariat Energie Atomique | METHOD AND DEVICE FOR HANDLING AND OBSERVING LIQUID DROPS |
WO2010019782A2 (en) | 2008-08-13 | 2010-02-18 | Advanced Liquid Logic, Inc. | Methods, systems, and products for conducting droplet operations |
WO2010077859A2 (en) | 2008-12-15 | 2010-07-08 | Advanced Liquid Logic, Inc. | Nucleic acid amplification and sequencing on a droplet actuator |
US8877512B2 (en) | 2009-01-23 | 2014-11-04 | Advanced Liquid Logic, Inc. | Bubble formation techniques using physical or chemical features to retain a gas bubble within a droplet actuator |
US8202736B2 (en) | 2009-02-26 | 2012-06-19 | The Governing Council Of The University Of Toronto | Method of hormone extraction using digital microfluidics |
TWI407146B (en) | 2009-06-10 | 2013-09-01 | Ind Tech Res Inst | Electrowetting display and method for fabricating the same |
WO2011002957A2 (en) | 2009-07-01 | 2011-01-06 | Advanced Liquid Logic, Inc. | Droplet actuator devices and methods |
WO2011020011A2 (en) | 2009-08-13 | 2011-02-17 | Advanced Liquid Logic, Inc. | Droplet actuator and droplet-based techniques |
US8926065B2 (en) | 2009-08-14 | 2015-01-06 | Advanced Liquid Logic, Inc. | Droplet actuator devices and methods |
US8846414B2 (en) | 2009-09-29 | 2014-09-30 | Advanced Liquid Logic, Inc. | Detection of cardiac markers on a droplet actuator |
US9091649B2 (en) | 2009-11-06 | 2015-07-28 | Advanced Liquid Logic, Inc. | Integrated droplet actuator for gel; electrophoresis and molecular analysis |
EP2516669B1 (en) | 2009-12-21 | 2016-10-12 | Advanced Liquid Logic, Inc. | Enzyme assays on a droplet actuator |
US9248450B2 (en) | 2010-03-30 | 2016-02-02 | Advanced Liquid Logic, Inc. | Droplet operations platform |
WO2012012090A2 (en) | 2010-06-30 | 2012-01-26 | Advanced Liquid Logic, Inc. | Droplet actuator assemblies and methods of making same |
WO2012009320A2 (en) | 2010-07-15 | 2012-01-19 | Advanced Liquid Logic, Inc. | Systems for and methods of promoting cell lysis in droplet actuators |
US20130168250A1 (en) | 2010-09-16 | 2013-07-04 | Advanced Liquid Logic Inc | Droplet Actuator Systems, Devices and Methods |
EP3193180A1 (en) | 2010-11-17 | 2017-07-19 | Advanced Liquid Logic, Inc. | Capacitance detection in a droplet actuator |
-
2011
- 2011-04-07 US US13/081,927 patent/US8637324B2/en active Active
-
2013
- 2013-11-15 US US14/081,376 patent/US8846410B2/en active Active
-
2014
- 2014-08-22 US US14/466,193 patent/US9081007B2/en active Active
-
2015
- 2015-06-05 US US14/731,740 patent/US9395361B2/en active Active
-
2022
- 2022-12-09 US US18/063,874 patent/US20230128722A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20150034485A1 (en) | 2015-02-05 |
US20110203930A1 (en) | 2011-08-25 |
US9081007B2 (en) | 2015-07-14 |
US20150268235A1 (en) | 2015-09-24 |
US8846410B2 (en) | 2014-09-30 |
US9395361B2 (en) | 2016-07-19 |
US8637324B2 (en) | 2014-01-28 |
US20140069812A1 (en) | 2014-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230128722A1 (en) | Bead incubation and washing on a droplet actuator | |
US11789015B2 (en) | Manipulation of beads in droplets and methods for manipulating droplets | |
WO2010042637A2 (en) | Bead incubation and washing on a droplet actuator | |
US8927296B2 (en) | Method of reducing liquid volume surrounding beads | |
US11525827B2 (en) | Bead incubation and washing on a droplet actuator | |
US8470606B2 (en) | Manipulation of beads in droplets and methods for splitting droplets | |
US8637317B2 (en) | Method of washing beads | |
US8317990B2 (en) | Droplet actuator loading and target concentration | |
US20150107995A1 (en) | Droplet Actuator Devices and Methods for Manipulating Beads | |
US9358551B2 (en) | Bead manipulation techniques | |
EP2212683A2 (en) | Manipulation of beads in droplets |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |